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Congenital anomalies and genetic diseases are the most important single causes
of disease and mortality in the first year of life in Western countries. There are, at
present, more than 500 disorders known in which the skeleton is involved. These
are mostly congenital disorders and are, in part, genetic in nature. The frequency of
each disorder is low but, as a whole, they constitute a significant body of disease in
childhood. These disorders lead to important diagnostic, clinical, genetic and
therapeutic challenges. Reliable estimates of its frequencies are scarce.
The complexity of skeletal disorders, the many types, the heterogeneity within
each type and the non-uniform terminology used in the international literature
caused a great deal of confusion in the classification in the past. Continuing efforts
over the years by a number of experts have helped to clarify well-known entities
and have delineated newer disorders. This resulted in the International
Nomenclature of Constitutional Diseases of Bone, which was issued in 1969 under
the auspices of the European Society of Paediatric Radiology (Maroteaux, 1970),
and subsequently revised in 1977, in 1983 and 1997 (Rimoin, 1998). The last
revision of the International Classification of Constitutional Disorders of Bone was
published recently (Hall, 2002). An on-line version is available on
http://www.csmc.edu/genetics/skeldys/  (see Appendix 2). The International
Nomenclature is based on the clinical, genetic and radiographic characteristics of
each condition. Additional delineation of disorders was done whenever specific
morphological or biochemical defects had been demonstrated. The arrangement
and subdivisions for nomenclature do not constitute a real classification and their
only purpose is to clarify the terminology and facilitate further research. The
terminology is rather descriptive, covering the aspect of the skeleton, the part of the
skeleton that is affected in radiographs or sometimes the consequences of the
abnormality.
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By definition, dysplasia is the process and the consequence of dyshistiogenesis,
which exists in cartilage and/or bone of the whole skeleton. Dysostosis, on the
other hand, is a disorder of individual bones as a single unit or in combination
(Brons and van der Harten, 1988).
The three major physiologic functions of bone cells are calcium transport,
biophysical or bioelectrical activities and hormonal responses. Normally,
osteoblasts form bone, osteocytes contribute to mineral matrix homeostasis and
osteoclasts resorb bone. Intrinsic or extrinsic factors capable of blocking or altering
these major physiologic functions could have far-reaching effects on developing
skeletal and connective tissue.
Many connective tissue disorders are believed to be caused by an abnormality in
collagen, the major structural protein of connective tissue. The system for collagen
production is complex, thus incurring the possibility of errors in the raw materials,
in the enzymes required for assembly, and in the assembly process itself.
Constitutional diseases of bone with a known pathogenesis include
chromosomal aberrations, metabolic abnormalities and especially also the
mucopoly-saccharidoses. Those with an unknown pathogenesis include
abnormalities of cartilage or bone growth and development, disorganised
development of cartilage and fibrous components of the skeleton, malformations of
individual bones, singly or in combination and abnormalities of density of cortical
diaphyseal structure, of metaphyseal modelling, or of both. Bone abnormalities
may also arise secondary to a disturbance in an extraskeletal system such as the
endocrine, haematological, neurological, neuromuscular, renal, gastrointestinal or
cardiopulmonary system.
In this thesis we will introduce another dysplasia to the list, called bilateral
hereditary micro-epiphyseal dysplasia (BHMED). Since BHMED has a number of
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features in common with multiple epiphyseal dysplasia (MED) as a broad and
heterogeneous group of skeletal disorders, first the literature on MED and MED-
like disorders is reviewed.
Even MED is a rare disorder. Its prevalence is estimated as 11.2 per 1 million
based on index patients, and 16.3 per million, if affected relatives are included
(Wynne-Davies, 1985). More recently, the prevalence has been estimated as
9:100,000 (Taybi and Lachman, 1996). In the Netherlands, one may expect about
168 to 244 patients with MED: every Dutch hospital cares for one or two patients
with MED on average. At the Reinier de Graaf Hospital in Delft (the Netherlands),
about 20 family members were known to have complaints with especially their hips
and knees, suspected to have a variant of MED, BHMED as formerly proposed by
Elsbach (1959). This was the starting point of a family study on the phenotypic
spectrum of BHMED
Elsbach described this dysplasia in 1959 (Elsbach, 1959). As a Dutch
orthopaedic surgeon, he examined family members on his outpatients’ department,
all with the same sort of complaints. These complaints started in the early
childhood, bilaterally, symmetrically and synchronically. Because of the
radiological finding of small epiphyses of the hip joint, he called his finding
bilateral hereditary micro-epiphyseal dysplasia (BHMED). Shortly after
publication he retired and until now there has been no follow-up study on this
family and its disorder.
Forty years later, we still have contact with the same family. Several members
of the original family were referred to the department of orthopaedic surgery in
Delft with questions about the genetic background, and the recurrence risk. We
extended the pedigree and re-examined the extended family, in order to evaluate
diagnostic criteria and the clinical course, to determine the clinical spectrum, and to
INTRODUCTION
___________________________________________________________________
6
provide tools for the diagnosis of possibly affected persons with only partial
expression of the disease.
During our investigations many members of the family told a remarkeble story
about their common grandfather, who in the midst of the 19th century, on a journey
through the Dutch Indies, was supposed to have been bitten by a crocodile. As far
as they remember, the disease appeared in their family from that moment on!
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In this thesis we will try to give a precise description of the phenotype as far as
possible in a family with a wide spectrum of complaints and give an answer to the
following questions:
1. Is BHMED indeed a separate clinical entity among the MEDs?
2. What are the diagnostic radiographic features of BHMED?
3. What is the molecular genetic basis of BHMED?
4. What is the diagnostic value of metacarpophalangeal pattern (MCPP)
profile analysis?

CHAPTER 3
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3.1. CLINICAL SYMPTOMS
In this chapter, the different clinical features of the multiple epiphyseal
dysplasias (MEDs) are reviewed. There are more than 100 disorders of cartilage
development, many of which are most likely due to genetic defects in the
macromolecular components of the growing or resting cartilage. A comprehensive
approach dealing with all forms of the disease is hampered by extensive clinical
overlap and undetermined levels of genetic heterogeneity. In this study, we will
focus on the clinical phenotypes of MED and a number of related disorders with
currently known genetic defects.
MED is one of the most common osteochondrodysplasias (Wynne-Davies and
Gormley, 1985) and the most common disorder in the group of generalized
epiphyseal disorders with predominantly limb involvement (Spranger, 1976). This
dysplasia was well described by Fairbanks in 1935. It is an ossification disturbance
of the epiphyses of the long bones, which leads to a serious deformation of the
involved joint. When the vertebrae are also affected, the term spondyloepiphyseal
dysplasia (SED) is used. Most forms of MED have an autosomal dominant pattern
of inheritance with a high penetrance and variable expression (Tachdjian, 1990). In
addition, at least one autosomal recessive form is known. The disease gives rise to
early-onset osteoarthritis of the major joints of especially of the lower limb, but
also of the upper limbs (van Mourik, 1993). Due to growth retardation of the
epiphyses of the tubular bones, short and stubby finger ends are seen. The contour
of the epiphyses is roentgenologically irregular and fragmentized with an
inhomogeneous osseous structure. The ossification centres appear at different
times, which gives the impression of stippled epiphyses which is due to the
multiple calcifications in or near the epiphyses.
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Originally, it was thought that shortness of stature and brachydactyly
constituted the basic features of MED, but subsequent studies recorded persons of
normal height and without digital abnormalities (Hoefnagel et al., 1967). In fact,
extensive clinical variability even within one family was observed, which suggests
that in addition to the major gene defect other factors determine the expression of
the disease. Maroteaux (1969) has defined MED as “a group of conditions in which
the changes in the long bones are limited to the epiphyses and the spinal lesions are
limited to the vertebral plates without notably affecting the height of the
vertebrae”. Today, this is probably the best definition available, although the
clinical boundaries of the different epiphyseal dysplasias are not easy to interpret.
With the possible exception of the pseudoachondroplasias, skeletal
abnormalities of the MED-type are not visible at birth. In fact, significant
manifestations are usually not seen until mid-childhood (ages six or seven). When
they do appear, the disturbances of the skeleton are likely to be bilateral and
symmetrical and, in contrast to those of the osteochondroses (Breck, 1971), involve
three or more joints. During childhood and adolescence it affects the epiphyses of
the tubular bones, resulting in axial deformities and sometimes in shorter limbs.
Later in life, MED may lead to early-onset osteoarthritis. Possibly, the non-specific
label of ‘bilateral premature osteoarthritis’, may sometimes in fact hide underlying
skeletal dysplasias like MED. Up until now, the diagnosis of MED was solely
based on physical examination and radiological survey. The presenting features of
MED include stiffness in the affected joints, development of pain, a limp or
waddling gait, difficulty in climbing stairs and running (Rimoin and Lachman,
1993; Dee, 1997). There is a limited range of motion in the affected weight bearing
joints. It is usually noted in childhood, sometimes in infancy, and occasionally only
incidentally in adult life. There is mildly short stature, with an adult height of rarely
145 cm and more usually around 160 cm, and short, broad hands and thumbs.
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Valgus deformities of the knees and ankles are common. In childhood, a deficiency
of the lateral part of the distal tibial ossification centre is seen, and this may
develop towards a sloping end of the tibia in adulthood. The diagnosis in the adult
is aided by the changes in the distal tibia. Facial appearance and intelligence are
normal (Leeds, 1960). 
Radiographic abnormalities of the skeleton appear after the third year of life
whereas there are usually none at birth (Beals and Horton, 1995). The most
important finding is the delay and irregularity of ossification of the involved
epiphyses. Radiographic appearance includes delayed appearance of the secondary
centres of ossification, including the proximal femoral ossification centre. There is
often a patchy, irregular ossification of the involved epiphyses, which is frequently
symmetrical on both sides and more pronounced in the lower extremities. In severe
cases, the adjacent metaphysis is also splayed and irregular. The limb epiphyses
gradually enlarge and the irregular areas coalesce. The capital femoral epiphyses
are nearly always involved and subsequently the femoral head is flattened,
sometimes with poor coverage and subluxation, and sometimes deeply set with a
protrusion of the acetabula. The acetabulum is occasionally normal, but more often
there is some loss of definition with a scalloped outline. In some reported families
no hip abnormalities were observed. There is a delay in the appearance of all
secondary ossification centres of the tubular bones, including the hands and wrists.
The epiphyses of all long bones can be affected and there may be some irregularity
of the end plates in the lower dorsal spine, but in general this is minor. Based on
the radiographic appearance of the pelvis and femoral heads, the disorder can be
confused with bilateral Legg-Calvé-Perthes’ disease, but the changes are
symmetric, and involve the metaphyses rather than the epiphyses of the hip.
Osteonecrosis may develop in addition to the underlying dysplasia, and it seems to
follow the same pattern of development as in Legg-Calve-Perthes’ disease. This
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latter disorder is still poorly understood, in aetiology as well as in treatment, with
controversies about all aspects. Although a metabolic basis for the disorder has
been suggested, up to the present day none has been found. Legg-Calvé-Perthes’
disease is bilateral in 15% of the cases, but it is rarely symmetric (Crossan et al.,
1983). Moreover, in contrast to MED, Legg-Calvé-Perthes’ disease is transient,
with initially an active phase of deterioration followed by improvement and
healing. MED shows only steady progression during growth (Crossan et al., 1983).
Bilateral Legg-Calvé-Perthes’ disease affects only the capital femoral epiphyses,
although growth and bone maturation may be delayed. In Legg-Calvé-Perthes’
disease there are patches of increased density in the capital epiphyses and often
clear metaphyseal involvement with cyst-like changes. The acetabulum is normal
or only very slightly affected (secondarily) by changes in the shape of the
developing femoral head. Generally, once re-ossification has started the potential
for further femoral head deformity is minimal, although new information suggests
that some hips become progressively flattened after onset of re-ossification. This
phenomenon is more likely to occur in older patients, in those with more severe
lateral pillar classification, and in those who have a prolonged re-ossification
phase.
MED can also but less frequently be confused with Meyer’s dysplasia, although
in this dysplasia, only the femoral head is affected on both sides. However, MRI
studies have shown that most patients actually have changes compatible with
superimposed avascular necrosis. The natural history of hip development in these
patients shows that all incongruent hips are osteoarthritic by the age of 20 (Meyer,
1964; Treble et al., 1990; Dee, 1997).
Patients with minor epiphyseal abnormalities of the shoulder have been shown
to develop painful osteoarthritis in middle age, but they retain shoulder movement
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until the degenerative changes are advanced. Those with a significantly deformed
‘hatchet head’, radiographic appearance of the humeral head were shown to have
had minimal glenohumeral movement from an early stage onwards, and this
condition often became painful by the fifth and sixth decades (Ingram, 1991).
Epiphyses may arise from more than one centre of ossification. The accessory
centres of ossification in MED are few in number and scattered at the periphery of
the cartilaginous epiphysis.
In MED, the metacarpals and phalanges are usually short and the finger ends are
stubby. The ‘V’ wrist-joint deformity in MED is due to hypoplasia of the adjacent
portions of the radial and ulnar epiphyses (Hoefnagel et al., 1967). The carpal
bones are small and irregular in MED.
The ‘slant sign’ of the ankle (thinning of the lateral part of the lower tibial
epiphyses), supposedly a characteristic feature of MED, is rather non-specific. A
‘flat-top’ talus is also seen in some MED subtypes. Flattening of the intercondylar
notch of the knee is a helpful early finding, but not specific for MED. Later, the
femoral condyles often show irregular ossification. Femoral head changes are
variable:  they may be absent, grossly deformed, irregularly ossified (as in Legg-
Calvé-Perthes’ disease), or normal (Barrie et al., 1958). Progressive flattening and
enlargement of the femoral head is characteristic in MED and eventually leads to
secondary osteoarthritis.
In MED, the vertebral bodies are of normal height but may show end-plate
irregularity. In the spine, there is not a real flattening or reduction of the vertebral
bodies, but the observed vertebral changes may be quite similar to Scheuermann’s
disease due to the intraspongious herniations of the lower thoracic or first lumbar
vertebrae. With the appearance of the apophyses, the rim of the vertebral body
shows fragmentation and, infrequently, a vertebral body will be fragmented
(Rubin, 1964).
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Radiographic anthropometric studies may be of some value in the early
diagnosis of MED (Poznanski et al., 1972; Ingram, 1992). Typical epiphyseal
changes may be present in the joints of apparently healthy family members. These
differences may depend upon the age, height, weight, and activity of the patient
(Silverman, 1968).
Clinically, MED was separated into two major forms of the disease, a severe
form known as the Fairbanks type, and a milder form, in which mainly the hips are
involved, known as the Ribbing type.
Clinical variability versus genetic heterogeneity is a major issue in MED and
related disorders. Forms of MED more severe than those reported by Fairbanks or
less severe than those reported by Ribbing have been described (Odman, 1959;
Cameron and Gardiner, 1963; Hulvey and Keats, 1969; Diamond, 1970). A number
of families have been reported in which MED was the presumptive diagnosis, but
with additional features such as spinal abnormalities suggestive of SED and early-
onset osteoarthritis of the major joints (Cameron and Gardiner, 1963), variable
spinal involvement (Hulvey and Keats, 1969), which led to attempts to distinguish
subforms on the basis of spinal abnormalities (Diamond, 1970). Marked
hyperextensibility of the fingers, early-onset osteoarthritis of the hips and short
stature were reported by Bachman and Norman (1967).
Villareal et al. (1992) wrote about a family with short hands and feet and,
radiographically, a short fourth metatarsal bone.
None of the known MED types involves the scapula, sternum, pelvis, ribs,
clavicle, mandible, skull, face, or teeth.
Stanescu et al. (1993) described similarities between the upper tibial cartilage of
MED-Fairbanks-type and pseudoachondroplasia (PSACH). They suggested that
both are allelic disorders.
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Pseudoachondroplasia (PSACH), formerly called pseudoachondroplastic
dysplasia, is not easy to differentiate from other severe forms of MED; but in the
former there is severe disproportionate dwarfing with very short limbs and marked
metaphyseal involvement. Some patients have striking joint laxity, a feature
seldom present in MED, but possibly present in the family described by Bachman
and Norman (1967).
PSACH is one of the most frequent skeletal dysplasias. The patients appear
normal at birth and growth retardation is seldom recognized until the second year
of life or later, at which time the body proportions resemble those of persons with
achondroplasia. The facies of patients with achondroplasia are similar and
normally shaped. The fingers are short and do not show the trident configuration
typical of achondroplasia. They are hyperlax and can be pulled out in a telescoping
fashion. Deformities of the lower limbs range from genu varum to genu valgum to
‘wind-swept’ deformity. Ligamentous laxity contributes to the leg deformities.
There is incomplete extension at the elbows and ulnar deviation of the wrists. The
child has a relatively long trunk, short extremities and increased lumbar lordosis.
The diagnosis of PSACH is easily made from pelvic radiographs. The development
of the whole pelvis is much delayed and disorganized, with poor formation of the
acetabulum and widening of the triradiate cartilage and epiphyseal and
metaphyseal changes most notable at the proximal and distal femoral ossification
centres (Apley and Solomon, 1993). Radiologically, all tubular bones are short
with widened metaphyses and fragmentation and irregularities of the developing
epiphyses. The epiphyses of the hips and phalanges are small, i.e., ‘mini
epiphyses’. In childhood, platyspondyly is characteristic, with anterior tonguing
due to delayed ossification of the annular epiphyses (Rimoin et al., 1994).
Langer et al. (1993) presented a 7½-year-old girl with achondroplasia ánd
PSACH. Her mother had achondroplasia and her father had PSACH. Langer et al.
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(1993) outlined the radiographic manifestations of these conditions and compared
the findings in this patient to those of achondroplastic and pseudoachondroplastic
patients of similar ages. Their review of these radiographs and of those of patients
with the Fairbanks type of MED led them to the conclusion that Fairbanks-MED
may be the mildest form of PSACH, a conclusion also suggested by the linkage
studies mentioned further on.
Stanescu et al. (1982) found an accumulation of a non-collagenous protein in
the rough endoplasmic reticulum of chondrocytes and the absence of a
proteoglycan ‘population’ from cartilage. The authors suggested that an abnormally
synthesized or processed protein core is not properly transferred to the Golgi
system.
To delineate the natural history of PSACH at all ages, Mc Keand et al. (1996)
collected questionnaire information on 79 affected individuals. The phenotype was
not distinct or more severe in familial cases as compared with new mutation cases.
Furthermore, there were no differences in the number of orthopaedic
complications, operations or number of offspring between these 2 groups. Less
than half the affected adults reported having a total hip replacement surgery.
Extraskeletal complications were generally uncommon. Premature osteoarthritis
was the major health problem.
SED versus MED
In view of spinal involvement in some families diagnosed with MED, the
question was raised whether MED and SED belong to a single major category of
skeletal dysplasias. In view of the description of one of his families, Maroteaux
(1969) seemed willing to accept a slight degree of platyspondyly in MED. 
On the other hand, SED may also show a large variety in the severity of spinal
abnormalities, and a wide range of additional clinical features is reported such as
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short trunk, barrel chest, increased thoracic kyphosis, marked lumbar lordosis, and
short limbs with relatively normal hands and feet, genu varum or valgum, muscular
hypotonia, waddling gait, and early mild degenerative changes of the hips. The
radiographic appearance of the skeletal system includes delayed ossification of the
pubic bone and the proximal and distal femoral epiphyses, pear-shaped vertebral
bodies in infancy, flattening and irregularity of ossification centres in childhood,
and severe vertebral flattening by adulthood. Dysplasia of the femoral head with
progressive degeneration is present. Hypoplasia of the odontoid process may lead
to cervical instability with spinal-cord compression. Kopits et al. (1974) described
a 12-year-old patient with chronic compression myelopathy of the cervical cord
due to habitual atlantoaxial dislocation. The usual presentation is generally one of
slowly progressive loss of motor strength.
A subtype of SED, spondyloepiphyseal dysplasia tarda (SEDT), is usually
diagnosed in adolescence and is considered to be an X-linked recessive condition
(Tachdjian, 1990; Ikegawa, 1993; Ikegawa et al., 1993). Clinical manifestations
include short stature, mainly short trunk, dorsal kyphosis and lumbar hyperlordosis,
and back and hip pain associated with progressive limitation of joint range of
motion, mainly hip flexion contractures. Radiographic appearance includes
platyspondyly with a hump-shaped deformity in the posterosuperior aspect of the
vertebral bodies and narrowed disc spaces seen on the lateral view. Ossification of
the upper and lower anterior margins of the vertebral bodies is absent (Wynne-
Davies et al., 1982; Wynne-Davies and Hall, 1982). 
Mild epiphyseal dysplasia with short femoral neck and coxa vara can be seen
with early degenerative changes of the hips; distal epiphyses of the long bones and
hands and feet are not affected.
Concerning the differential diagnosis of the different epiphyseal dysplasias, it is
a problem to define clear-cut boundaries between the different phenotypes. Rarely
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two families with the same disorder or two members of the same family show
similar patterns of involvement. Furthermore, one or two members within an
affected family with the diagnosis of a MED-like disease may demonstrate findings
suggestive of another condition, e.g., SED or PSACH. In addition, the clinical
variability does not only manifest itself in the autosomal dominant forms, but may
also be present in families with apparently autosomal recessive patterns of
inheritance. 
3.2. GENETIC ASPECTS 
Over 100 unique skeletal dysplasia phenotypes have been clinically defined
(International Working Group on Constitutional Diseases of Bone, Hall, 2002;
http://www.csmc.edu/genetics/skeldys/ ). The primary features that separate one
phenotype from another are clinical presentation and natural history, radiographic
abnormalities, inheritance pattern and morphology of cartilage or bone. In a few of
these disorders, the primary genetic defects have been identified, but the majority
are aetiologically undefined.
Spranger (1985) has proposed classifying clinically similar phenotypes that
likely share a common pathogenetic mechanism into bone dysplasia families while
recognizing the great diversity in phenotypes associated with genetic defects in a
specific pathway. Indeed, allelic disorders may span a spectrum of clinical severity
depending on the nature of the mutation in the gene or genes that encode the
molecule of interest. This concept fits the known variability of osteogenesis
imperfecta phenotypes, all of which can result from dominant mutations in type I
procollagen genes (Byers, 1990). Similarly, type II procollagen gene mutations
have been characterized in individuals with phenotypes that range from the
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perinatal lethal achondrogenesis type II phenotype to Stickler syndrome (arthro-
ophthalmopathy) which is well compatible with adult life (Lee et al., 1989; Vissing
et al., 1989; Ala-Kokko et al., 1990; Tiller et al., 1990; Ahmad et al., 1991; Ahmad
et al., 1993; Chan and Cole, 1991; Horton et al., 1992; Bogaert et al., 1992; Brown
et al., 1992; Winterpacht et al., 1993; Vikkula et al., 1993).
Similarly, clinical, morphological and histological features suggested that
PSACH and the Fairbanks type of MED belong to the same distinct bone dysplasia
family (Stanescu et al., 1993; Rimoin et al., 1994).
Though most MED conditions appear to have autosomal dominant inheritance,
autosomal recessive types have also been reported, making them one of the first
indicators of genetic locus heterogeneneity and different kinds of pathway
involved. Juberg and Holt (1968) tabulated 11 reports in which more than one
member of a sibship was affected while the parents were normal and often related.
These cases included those of Barrington-Ward (1972), Ribbing (1937), Fairbanks
(1947), Lodes (1949), Emr (1952), Watt (1952), Waugh (1952), Litchman and
Chirls (1958) and families 28, 31 and 37 of Hoback (1961). Of course, one has to
keep in mind the possibility that multiple affected siblings with unaffected parents
may also represent cases of parental mosaics for an autosomal dominant gene
defect, especially when the frequency of parental consanguinity is much lower than
expected relative to the frequency of the disorder and the frequency of
consanguinity in the general population studied. Secondly, the same gene may
sometimes be involved in both AD and AR variants of the disease.
Based on thorough and careful clinical evaluation and radiological examination,
different phenotypes within the MED spectrum can be distinguished. Indeed,
genetic studies including linkage analysis, whole genomic searches and mutation
analysis revealed at least five possible loci for MED, EDM1-5.
REVIEW OF THE LITERATURE
___________________________________________________________________
24
EDM1. The first gene for MED that was discovered was the COMP gene. By
linkage studies, Oehlmann et al. (1993) mapped a locus for MED close to the
centromere of chromosome 19. The highest LOD-score was observed for
D19S199: maximum LOD = 4.67 at theta = 0.09. Subsequently, Oehlmann et al.
(1994) reported a maximum LOD score of 6.37 at theta = 0.05 for linkage with
D19S215. Multipoint linkage analysis indicated that MED was located between
D19S212 and D19S215, a map interval of 1.7 cM. The gene for PSACH was
mapped also to the pericentric region of chromosome 19. This finding, combined
with the morphologic similarity between PSACH and MED suggested the
possibility of allelism of the two disorders.
Deere et al. (1995) confirmed the linkage of autosomal dominant MED to
D19S212, maximum LOD = 3.22 at theta = 0.00. However, in another family in
which three of seven sibs were affected and the parents were unaffected, they
excluded linkage to chromosome 19 (using both autosomal recessive and
autosomal dominant models, with either reduced penetrance or germline mosaicism
considered). Linkage to a number of other candidate genes, COL9A1, COL9A2
and COL11A2, was tested and excluded for both genetic models in the latter
family. 
Knowlton et al. (1995) further narrowed the possible location of the
EDM1/PSACH gene to an interval of approximately 600 kb which included the
COMP gene as a candidate gene. Subsequently, mutations in the COMP gene were
found in both MED and PSACH (Hecht et al., 1995; Briggs et al., 1995),
confirming that at least one form of MED and PSACH represent allelic disorders. 
Table I summarizes the currently known allelic variants of COMP and
associated phenotypes.
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Table I. Allelic variants (selected examples) of cartilage oligomeric matrix protein
(COMP) according to OMIM.
Allelic variant Author/year Nucleotide Result
PSACH [COMP,ASP472TYR] Hecht 
et al., 1995
G-to-T
transversion
1439 Asp472-to-tyr
Aa substitution
PSACH [COMP,CYS468TYR] Hecht 
et al., 1995
G-to-A
transition
1428 Cys468-to-tyr
Aa substitution
PSACH [COMP,3-BP DEL,
459TCA, SER459DEL]
Hecht 
et al., 1995
deletion 1400-1402
TCA
Serine-459 
deletion
PSACH [COMP,3-BP DEL, ASP
DEL, (GAC)4]
Hecht
et al., 1995
deletion 3-bp 1430-1445
cDNA
Loss of aspartate
residue in a
calcium-binding
site
PSACH [COMP,3-BP DEL, ASP
DEL, 9GAC)4]
Briggs
et al., 1995
deletion 3-bp 1139-1147 Elimination of
aspartic acid
codon (372-374)
MED
(Fairbanks)
[COMP,ASP342TYR] Briggs 
et al., 1995
Tyr for asp
substitution
RsaI restriction
endonuclease
cleavage site
PSACH [COMP,CYS328ARG] Briggs
et al., 1995
Cys328-to-
arg
substitution
Conserved
residue in
second
calmodulin-like
repeat
MED
(Ribbing)
[COMP,ASN523LYS] Ballo
et al., 1997
C-to-G
transversion
1594 Asn523-to-lys
Aa substitution
MED
(Fairbanks)
[COMP,ASN453SER] Briggs
et al., 1998
1383A-G
transition
Exon 13 Asn453-to-ser
(N453S) Aa
substitution
PSACH [COMP,ASP473GLY] Ikegawa 
et al., 1998
1418A-G
transition
Asp473-to-gly
Aa substitution
PSACH [COMP,(GAC)5,(GAC)7] Delot
et al., 1999
(GAC)5
repeat
expansion
1430-1444
cDNA
(GAC)5,(GAC)7
MED
(EDM1)
[COMP,(GAC)5,(GAC)6] Delot
et al., 1999
(GAC)5
repeat
expansion
(GAC)5,(GAC)6
McKusick (OMIM, http://www3.ncbi.nlm.nih.gov/htbin-post/Omim/dispmim?132400,
2002) suggested in his discussion of Fairbanks and Ribbing type MED that  “…
Fairbanks multiple epiphyseal dysplasia is probably the same as that described as
enchondral dysostosis by Odman (1959) and that described as ‘microepiphyseal
dysplasia’ by Elsbach (1959)…”. Clearly, this assumption requires confirmation or
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rejection on the basis of further phenotypic and molecular genetic analysis, which
is one of the main subjects of this thesis. 
EDM2. After the discovery of the COMP gene, a number of other genes
involved in the different forms of MED were identified. MED linked to
chromosome 1p33-32.2 (EDM2) (Briggs et al., 1994) is also an autosomal
dominant form of MED and the gene mutated in a Dutch family with this disorder
turned out to be the COL9A2 gene (Muragaki et al., 1996). It encodes the α2 chain
of type IX collagen, a structural component of the cartilage extracellular matrix
(Warman et al., 1994). Affected individuals typically presented at 2.5 to 6 years of
age with pain in the knees. Knee and ankle pain were present throughout
childhood. 
In some individuals, bilateral osteotomies were required for gross varus
deformities of the knees. Hands were mildly short and joints prominent. There
were no abnormalities of the spine and chest. Examination of the X-rays showed
flattened, irregular epiphyses in most joints, particularly in the knees (Briggs et al.,
1994; Barrie et al., 1958). Table II summarizes the currently known allelic variants
of EDM2 and associated phenotypes of COL9A2.
Table II. Allelic variants (selected examples) of COL9A2 according to OMIM.
Allelic variant Author/year Site Result
MED
(EDM2)
[COL9A2, IVS3DS,
T-C, +2]
Muragaki 
et al., 1996
Gt-to-Gc
transition
Position +2
of intron 3
In-frame loss of 
12 amino acids
MED
(EDM2)
[COL9A2, G-A, 
EX3, -1]
Holden 
et al., 1999
G-to-A
transition
Exon 3 CCG(pro) to
CCA(pro) in the 
last codon of exon 3
MED
(EDM2)
[COL9A2, IVS3DS,
G-C, +5]
Holden 
et al., 1999
G-to-C
transversion
Position +5
of intron 3
Interverte-
bral disc
disease
[COL9A2,
GLN326TRP]
Annunen 
et al., 1999
TRP-to-GLN
substitution
Tryptophan for
glutamine substitution
at codon 326
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EDM3. A third locus for autosomal dominant MED (EDM3) was found on
chromosome 20q13.3 (Paassilta et al., 1999). Subsequent mutation analysis of the
positional and functional candidate gene COL9A3 showed an A-to-T conversion at
the acceptor splice site of intron 2 of this gene. Bönnemann et al. (2000) described
another family with the same form of MED, stressed the importance of myopathy
as part of the phenotype, and found – through linkage and mutation analysis and
mRNA analysis of a muscle biopsy specimen – also an acceptor splice site
mutation of intron 2, leading towards skipping of exon 3. Other variants of this
gene seem to be a risk factor in the occurrence of a more common degenerative
intervertebral disc disease, as observed by Paassilta et al. (2001) who found an
Arg103Trp (R103W) substitution to be associated with disease cases when
compared to controls (12.2% versus 4.2%, RR for the allele about three). 
EDM4. The fourth type, called EDM4, is responsible for an autosomal
recessive form and is caused by a mutation in the DTDST gene on chromosome
5q32-q33.1 (Superti-Furga et al., 1999; Huber et al., 2001; Czarny-Ratajczak et al.,
2001). Maroteaux et al. (1975) suggested that the recessive form of MED may
differ from the dominant form with respect to the presence of a flat femoral head
and lack of metaphyseal irregularities in the metacarpals and phalanges.
Chondrocytes contain inclusions with granular or filamentous material, probably of
lysosomal origin. One publication stated a homozygous DTDST mutation
(R279W) in a male subject, with bilateral clubfoot, surgically corrected in
childhood, and a bilateral double-layered patella at 8 years of age (Superti-Furga et
al., 1999).
EDM5. The finding of a fifth locus for MED illustrated again the extensive
locus heterogeneity of MED. Chapman et al. (2001) described an autosomal
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dominant form of MED with knee and hip pain after exercise from early childhood,
mild shortness at adult age, multiple epiphyseal dysplasia, early-onset osteoarthritis
and a normal spine. Through linkage and mutation analysis they were able to
exclude the other loci and to localize the disease on chromosome 2p23-24.
Subsequently, the matrilin-3 (MATN-3) gene in this region was identified by
Belluoccio et al. (1998) as the one that, if mutated, is causing the disease (two
different mutations associated with the disease in two different families). 
MATN-3 belongs to a larger group of matrilins that constitute a subfamily of
extracellular matrix proteins containing the von Willebrand factor type A (vWFA)-
like domain. The vWFA-like domain was first described in von Willebrand factor
where it plays a key role in promoting platelet adhesion to the subendothelium.
Several vWFA-like domains have been implicated in interactions with collagen.
Cartilage matrix protein, also called matrilin-1, and matrilin-2 were the first 2
members of the family to be described. 
Chapman et al. (2001) performed a genome wide screen of a 4-generation
family with an autosomal dominant form of multiple epiphyseal dysplasia, not
linked to COMP, COL9A2 or COL9A3, respectively, and found significant
evidence for a MED locus on the short arm of chromosome 2 at 2p23-24. Matrilin-
3 was found in the critical region. Chapman et al. (2001) identified two different
missense mutations in the exon encoding the von Willebrand factor A domain of
MATN-3 in two unrelated families with MED. Table III summarizes the currently
known allelic variants of MATN-3 and associated phenotypes, which all show an
autosomal dominant pattern of inheritance.
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Table III. Allelic variants (selected examples) of multiple epiphyseal dysplasia (MED),
MATN-3 related according to OMIM.
Allelic variant Author/year MATN3 gene Result
MED
(EDM5)
[MATN3,VAL194ASP] Chapman
et al., 2001
A-to-T
transversion
Position 598 Valine-to-aspartic
acid substitution
at codon 194
MED
(EDM5)
[MATN3,ARG121TRP] Chapman 
et al., 2001
C-to-T
transversion
Position 378 Arg-to-trp acid
substitution at
codon 121
MED
(EDM5)
[MATN3,ALA128PRO] Mostert 
et al., 2003 
G-to-C
transversion
Position 382
Exon 2
Alanine-to-proline
acid substitution
at codon 128
3.3. PATHOGENESIS 
Many skeletal dysplasias have an unknown aetiology and molecular
pathogenesis. In view of the scope of this thesis, special attention will be paid to
what is known about the molecular properties of matrilin-3 (MATN-3), a newly
discovered member of the novel extracellular matrix protein family. 
The matrilin family consists at least of four members (Deák et al., 1999).
Whereas MATN-2 and -4 are mainly expressed in non-cartilaginous tissues such as
bone and lung, MATN-1 is expressed specifically in the pre-hypertrophic mature
zone of a growth plate (Chen et al., 1995). MATN-3 has been found in developing
cartilage (Wagener et al., 1997). 
All the members of matrilin family contain van Willebrand factor A domains,
epidermal growth factor (EGF)-like domains, and a heptad repeat coiled-coil
domain at the carboxyl terminus, which is responsible for the oligomerization of
the molecule (Beck et al., 1996; Haudenschild et al., 1995).
MATN-1, -2, and -4 contain two A domains (A1 and A2) separated by EGF-
like domains, whereas MATN-3 lacks the A2 domain (Wagener et al., 1997). The
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A2 domain is near the coiled-coil domain and may modulate oligomerization of
matrilins (Zhang and Chen, 2000), whereas the A1 domain is not involved in this
oligomer formation process (Chen et al., 1999). MATN-1 contains only one EGF-
like domain, whereas MATN-3 contains four such domains. MATN-2 and -4 also
contain multiple EGF repeats (Deák et al., 1999). 
Among all the matrilins, the position and number of cysteines in every
corresponding domain is conserved (Deák et al., 1999). Each A domain has two
cysteines, one at the NH2 terminus and one at the COOH terminus. Each EGF-like
domain contains six cysteines. There are two additional cysteines at the NH2
terminus of the coiled-coil domain. Two such cysteines in MATN-1 (Cys455 and
Cys457) seem to be responsible for forming intermolecular disulfide bonds linking
MATN-1 sub-units together (Haudenschild et al., 1995). 
Zhang and Chen (2000) demonstrated that MATN-3 mRNA is mainly
expressed in the proliferation zone of a growth plate. It is also expressed in the
maturation zone, overlapping with that of the MATN-1 mRNA which is abundant
in mature chondrocytes. This suggests that MATN-3 self-assembles in the
proliferation zone, as well as co-assembles with MATN-1 during enchondral
ossification. Transfection of a MATN-3 cDNA into COS-7 cells shows indeed that
MATN-3 predominantly forms a homotetramer but also a trimer and a dimer. Co-
transfection of both MATN-3 and MATN-1 cDNAs results in three major matrilins
that can be represented in the following formulas: (MATN-1)3, (MATN-3)4, and
(MATN-1)2(MATN-3)2. Thus, MATN-3 may assemble into both homotypic and
heterotypic oligomers. Analysis shows that the assembly of MATN-3 does not
depend on the number of epidermal growth factor repeats within the molecule, but
the presence of Cys412 and Cys414 within the coiled-coil domain, which form
covalent disulfide linkage responsible for both homo-oligomerization of MATN-3
and hetero-oligomerization of MATN-3 and MATN-1. These data suggest that the
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varying synthetic levels of matrilins in different zones of a growth plate may result
in a change of matrilin oligomeric forms during enchondral ossification.
Full-length MATN-3 and a fragment lacking the assembly domain were
expressed in 293-EBNA cells, purified, and subjected to biochemical
characterization. Recombinantly expressed full-length MATN-3 occurs as
monomers, dimers, trimers, and tetramers, as detected by electron microscopy and
SDS-polyacrylamide gel electrophoresis, whereas MATN-3 purified from fetal calf
cartilage, forms homotetramers as well as hetero-oligomers of variable
stoichiometry with MATN-1. In the matrix formed by cultured chondrosarcoma
cells, MATN-3 is found in a filamentous, collagen-dependent network connecting
cells and in a collagen-independent pericellular network. 
These findings are in agreement with the observation that fetal growth cartilage
contains homotrimeric molecules of MATN-1, homotetrameric molecules of
MATN-3, and the assorted chain combinations of MATN-1 and -3 in
heterotetramers. In addition, affinity-purified antibodies detect MATN-3
expression in a variety of mouse cartilaginous tissues, such as sternum, articular,
and epiphyseal cartilage, and in the cartilage anlage of developing bones. It is
found both inside the lacunae and in the interterritorial matrix of the resting,
proliferating, hypertrophic, and calcified cartilage zones, whereas the expression is
lower in the superficial articular cartilage. In trachea and in costal cartilage of adult
mice, an expression was seen in the perichondrium. Furthermore, MATN-3 is
found in bone, and its expression is, therefore, not restricted to chondroblasts and
chondrocytes.
In a cartilaginous growth plate, extracellular matrix (ECM) molecules mediate
cell-matrix and matrix-matrix interactions, thereby providing tissue integrity and a
matrix permissible for chondrocyte differentiation and subsequent ossification.
Some members of matrilins showed to be expressed specifically in developing
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cartilage rudiments but not in adult articular cartilage, suggesting significant
differences in temporospatial expression patterns of the genes encoding the various
components (Wu and Eyre, 1998; Deák et al., 1999). The prototype of the matrilin
family, cartilage matrix protein/MATN-1, has been shown to interact with both
collagens (Winterbottom et al., 1992) and aggrecans (Paulsson and Heinegård,
1979). Thus, matrilins may play an important role in the assembly of the ECM
networks (Chen et al., 1999).
MATN-2 (Deák et al., 1997; Piecha et al., 1999) and MATN-4 (Wagener et al.,
1998 (1); Wagener et al., 1998 (2)) have a much broader tissue distribution than
MATN-1 (Paulsson and Heinegård, 1979; Paulsson and Heinegård, 1982; Aszódi
et al., 1996) and MATN-3 (Wagener et al., 1997; Belluoccio and Treub, 1997;
Belluoccio et al., 1998) which are more restricted to skeletal tissues, but the
identification of the co-assembly product, a heterotetramer (MATN-1)2(MATN-3)2,
from growth cartilage (Wu and Eyre, 1998) suggested that although the synthesis
of the two matrilins are not necessarily spatially identical they do show regional
overlap.
The matrilins represent an example of genes identified and functionally
analyzed without knowledge of human diseases that may be linked to structural of
functional alterations of these genes. The finding of MATN-3 mutations in MED
variants including BHMED changed this perspective.
3.4. COURSE AND TREATMENT 
There is no specific therapy for MED and MED-related disorders. Problems
with MED vary little from problems of normal peers. Early detection is important
for purposes of genetic counselling, recreation, and occupation. Affected patients
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should be aware that genes causing structurally weak epiphyses may be involved
and could be passed on to offspring. Those with weak joints should be warned to
avoid recreational or occupational activities particularly traumatic to their joints.
Knowledge of the diagnosis and heritable basis of the short-stature conditions
might save needless loss of time and expense in hospital visits or admissions,
extensive diagnostic work-ups to exclude numerous other causes, and such (Bailey,
1973). The management of MED is also directed towards the prevention of
contractures. If they occur in the severe cases, even in the newborn period, they can
lead to bony curvatures, angulations, and rotational deformities. As stippling
subsides, there is a tendency for contractures to subside, which in turn allows
spontaneous correction of secondarily curved or angulated bones. Stretching
exercises, sometimes supplemented by plaster casts (usually for foot deformities
such as calcaneovalgus feet or clubfoot), are usually adequate. Rotational limb
deformities caused by soft tissue also respond to proper positioning (and avoidance
of a deforming position), postural and stretching exercises, and casts or braces.
Remodelling may be stimulated by continuous passive motion (CPM) of major
joints, especially hip and knee (Tachdjian, 1990). The management of epiphyseal
dysplasia is also directed towards care of the inevitable osteoarthritis. In severe
joint incongruity, axial or rotational deformities of bone with the failure of
conservative management, corrective osteotomies, such as pelvic and distal
femoral osteotomy, may be indicated and required. Osteotomies performed before
closure of the epiphyseal plates gave only palliative correction and the deformities
tended to recur (Amir et al., 1985). However, disabling deformities, also in
growing children, are an indication for surgery, also when there are loose bodies in
the joints. Degenerative osteoarthritis may be treated by total joint arthroplasty.
Patients may also benefit from counselling on body weight and carrier advice.
Reduction of late osteoarthritic change may be achieved by restriction of physical
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activities in sports and work, and advice on how to take physical exercise (Murphy
et al., 1973). Primary prevention is only possible by means of genetic counselling
(Maroteaux, 1979).
As in all skeletal dysplasias showing involvement of the spine, the odontoid
process should be evaluated as a routine part of the work-up and certainly prior to
any surgical procedure. Though only mild to moderate hypoplasia of the odontoid
process is the rule, because of the variable nature of the bony disease, an occasional
patient shows atlanto-axial instability from severe mal-development. An instability
frequency of two in 17 was found in the patients of Afshani and Girdany (1972).
Lateral flexion and extension roentgenograms of the upper cervical spine, as well
as an open-mouth anteroposterior view, are usually an adequate evaluation. When
instability is found, surgical spondylodesis is recommended. If scoliosis develops,
treatment of the scoliosis is also necessary.
The course and treatment of MED depends on the severity of the affected and
incongruent, arthritic joints. As the patient grows, joint pain and early-onset
osteoarthritis develop, sometimes with joint contractures. Early-onset osteoarthritis
is more likely when the epiphyseal ossification is fragmented, the femoral head is
deformed and poorly covered, and the acetabulum is dysplastic. From the
orthopaedic point of view, severe arthritic joints can undergo a joint replacement or
in an earlier phase a correction osteotomy, but recurrent deformity is common.
Whether osteotomies that are performed to improve biomechanics can alter the
natural history of early-onset osteoarthritis is uncertain. A conservative treatment is
pursued for as long as possible. 
The comparison between the clinical features of the five currently known EDMs
is shown in Table IV.
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In the autosomal dominant EDM1 type, most complaints are bilateral in the hips
and knees. 
Shoulder disability is also common, and minor epiphyseal abnormalities can
lead to painful osteoarthritis, while severe deformity or ‘hatchet head’ shoulder
result in severe joint limitation at an early age. The hands are clearly involved, with
short metacarpals and phalanges and stubby finger ends. Other deformities are
scoliosis and valgus ankles, associated with disordered epiphyseal growth. The
range of severity of multiple epiphyseal dysplasias is wide, ranging from only local
involvement discovered incidentally, to widespread involvement with crippling
osteoarthritis and short stature.
In the autosomal dominant EDM2 type, the milder dysplasia, hip and knee
complaints are less important although there is a limited joint function and
waddling gait. In the study of van Mourik (1998), there were mostly complaints
and radiological abnormalities of the knee, elbow, ankle, wrist, hand and foot
joints. The shoulders were not involved. Only in two cases the hips showed
temporarily slight deformities of the proximal femoral epiphyses. The epiphyses of 
the major joints were also small and sometimes irregularly shaped. Spine
deformities were short stature was explained by these abnormalities, although in
the study of van Mourik (1998) the total body height is not significantly different
from the control population. The hands and wrists appeared to be unaffected,
although brachydactyly was reported.
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Table IV. Comparison of the clinical features of the five currently known types of EDM.
EDM1/COMP/PSACH EDM2 EDM3 EDM4 EDM5
19p13.1 1p33-
p32.2
20q13.3 5q32-
q33.1
2p23-24
Ik
eg
aw
a 
et
 a
l.,
 1
99
8
D
ee
re
 e
t a
l.,
 1
99
9
D
ee
re
 e
t a
l.,
 1
99
5
B
al
lo
 e
t a
l.,
 1
99
7
W
ea
ve
r e
t a
l.,
 1
99
3
O
eh
lm
an
n 
et
 a
l.,
 1
99
4
B
rig
gs
 e
t a
l.,
 1
99
4
M
ou
rik
  v
an
, 1
99
8
Pa
as
si
lta
 e
t a
l.,
 1
99
9
B
ön
ne
m
an
n 
et
 a
l.,
 2
00
0
Su
pe
rti
-F
ur
ga
 e
t a
l.,
 1
99
9
G
am
bo
a 
an
d 
Li
sk
er
, 1
97
4
C
ha
pm
an
 e
t a
l.,
 2
00
1
El
sb
ac
h,
 1
95
9
M
os
te
rt 
et
 a
l.,
 2
00
2
Pedigree generations 3 4 3 5 4 5 4 3 4 4 6
AD/AR AD AD AD AR AR AD AD AD
Onset complaints 10 40 4
Bilateral Y Y Y Y
Early-onset arthritis Y Y Y Y Y Y Y Y
Limited joint function Y Y Y N Y
Small/irreg. epiphyses Y Y Y Y
Short stature Y Y Y Y Y Y Y
TBH ↓ ↓ <3% <3% <3%
Myopathy N Y N N N
Gower sign N Y N N
Routine lab.  abnorm. Y N
Short MC IV & V Y
Short hands N Y Y N Y N
Brachydactyly Y Y N N N N
Ulna plus N Y
Complaints elbow Y N
X-spine deformities Y Y Y Y Y N N N
Limping/waddling gait Y Y Y Y Y Y Y Y
Esp. hip complaints Y Y Y N N Y Y Y
Valgus femoral neck N Y
Short/thick  fem. neck Y N Y Y
Flattened fem. head Y N Y Y
Acetabulum  involved N Y
Esp. knee complaints Y Y Y N Y Y Y Y
Shallow notch  knee Y Y Y Y Y
Patella deformity N Y N N
Sloping distal tibia Y Y Y Y Y Y Y
Club feet N Y N
Complaints ankle Y N
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In the autosomal dominant EDM3, mostly complaints of the knees, ankle and
elbow are reported. Although there is a waddling gait, no hip abnormalities were
reported and the radiological features of the hip were normal. There is a general
weakness of the muscles, with for example a positive Gowers’ sign and elevated
CK levels. No hand deformations are seen. Life expectancy seems to be normal.
The autosomal recessive EDM4 type is a mild dysplasia with a late onset of
complaints of the major joints, around 40 years of age. A waddling gait is present
and radiologically, the hip shows a flattened head and the collum femoris is
shortened and thickened. The bilateral clubfoot, reported by Superti-Furga et al.
(1999) is usually corrected in childhood. They also mentioned a bilateral double-
layered patella at 8 years of age which can be treated conservatively. Life
expectancy seems to be normal.
The autosomal dominant EDM5 is also a clinically variable dysplasia. Hip and
knee complaints start in early childhood by frequent falling, difficulty in climbing
the stairs and running. When the osteoarthritis of the major joints is severe, joint
replacement arthroplasty follows. The shoulder is free of symptoms till the 5th
decade. After that, a painful movement develops and radiological symptoms of
arthritis can be seen. The other joints, like elbow and ankle show only
radiologically small epiphyses, but function and stability are normal. The life
expectancy seems to be normal.
In summary, the therapeutic approach is more or less the same for all EDM
variants, but systemetic follow-up and comparison is lacking.
Large intra- and interfamilial variation in phenotype, incomplete examination of
patients and until recently lack of knowledge about the genes and mutations
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involved in MED have hampered the development of a set of reliable features that
distinguish the different variants of MED with respect to its diagnosis and
prognosis as well its response to different treatments.
It appears that osteoarthritis may complicate any of the currently known EDMs.
However, in most reports, the phenotypic description is limited, and follow-up
studies providing information about the natural course of disease and effect of
treatment are virtually absent.
Social implications
Although there are no specific social implications related to any form of the
EDM related families, affected family members show, in case of early-onset
osteoarthritis, limitations in their occupation and daily life. These limitations are
the same as those in an idiopathic arthritis, without the presence of any kind of
dysplasia. It is believed, that heavy weight bearing should be discouraged, based on
the joint incongruency or dysplastic development of the different joints. When a
joint is poorly covered with articulating surface or when the cartilage is of a lesser
quality, it is expected that due to weight bearing the joint is prone to develop an
early degeneration, but here the literature is not conclusive.
However, these guidelines are not yet evidence based in view of the absence of
adequate follow-up studies that include medical and social endpoints. When the
intelligence is normally developed, a regular career can be expected.
The existence of MED in families with an autosomal dominant pattern of
inheritance suggests that reproductive fitness is not necessarily reduced in these
skeletal dysplasias. Only large population-based studies will enable us to make
more precise conclusions about marriage rates and fertility in male and female
patients. Even if reproductive fitness werebe undisturbed, one may expect that
MED variants characterized by shortened stature may lead towards height-related
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partner choice and thus continued gene influx from a polygenetic background for
short stature in subsequent generations of familial autosomal dominant MED. This
issue will also be addressed in this thesis. 
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ABSTRACT
Bilateral Hereditary Micro-Epiphyseal Dysplasia (BHMED) is a distinct entity
in the group of skeletal dysplasias on the basis of specific clinical and radiological
findings. The family originally published by Elsbach [5] in 1959 was re-examined
for further delineation of the phenotype. Especially the hip and knee were affected
bilaterally and simultaneously with small epiphyses and osteoarthritis at an early
age. In addition, some subjects showed shortening of metacarpals IV and V. A
small adult height, associated with BHMED, proved to be comfounded in this
family by height related partner choice. Future linkage analysis and
characterisation of the molecular defect causing BHMED will clarify whether this
disorder is allelic to other known skeletal dysplasias like multiple epiphyseal
dysplasia, or is due to a mutation of a novel gene.
INTRODUCTION
Bilateral hereditary micro-epiphyseal dysplasia (BHMED) is a rare, usually
symmetrical skeletal dysplasia first reported by Elsbach [5] in 1959. In the family
he described, several members complained mainly of pain in hips and knees from
early childhood. 
Because of the radiological finding of small epiphyses in the hip and knee joint,
Elsbach designated the disorder bilateral hereditary micro-epiphyseal dysplasia.
BHMED should be differentiated from multiple epiphyseal dysplasia (MED), in
which the epiphyses have a (relatively) normal size.
Recently, several members of the original family were referred to the
department of orthopaedic surgery in Delft with questions about the genetic
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background, and the recurrence risk. We re-examined the extended family, in order
to evaluate diagnostic criteria and the clinical course, to determine the clinical
spectrum, and to provide tools for the diagnosis of possibly affected persons with
only partial expression of the disease.
PATIENTS AND METHODS 
Clinical examination. The pedigree was updated and contained 54 subjects in
six generations (Fig. 1). Thirty-two members of the family and 12 spouses were
examined by the first author (A.K.M.). A full medical history was taken according
to a standardised questionnaire. Physical examination was performed according to
a standard protocol. The range of motion of hip, knee, and shoulder joints was
measured according to guidelines (4th edition) of the American Medical
Association [4]. Total body height, sitting height, leg length, and span width were
measured and compared with reference data from the Dutch population [2]. 
Prior and additional radiographs of first- and second-degree family members
complaints were evaluated by one of the authors (P.F.D.). In some of the cases,
results of laboratory tests of serum calcium, phosphate and alkaline phosphatase
levels were available and collected.
Diagnostic criteria. All subjects over 4 years old were classified clinically and
radiologically as affected, unaffected, or inconclusive (included not known).
Clinical classification. The original clinical description by Elsbach [5] was used
as the basis for the clinical diagnosis of BHMED. Diagnostic criteria for clinical
affection status were bilateral simultaneous onset of pain in hip and knee joints,
short  stature, waddling  gait and restricted  range of motion of the hip. Patients and
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relatives who fulfilled all clinical diagnostic criteria were categorised as affected
(group I). Subjects who did not fulfil all diagnostic criteria, or who were not
examined or only incompletely examined were categorised as inconclusive with
respect to clinical affection status (group II). Patients who showed no clinical signs
of BHMED were categorised as unaffected (group III). 
Radiological classification. All radiographs were reviewed by a radiologist
specialised in skeletal dysplasias (P.F.D.), without knowledge of the clinical
evaluation or the a priori risk for the condition. The diagnostic criteria for
radiological affection status were (a) a hip characterised by valgus angle of the
femoral neck [8] which is short and thickened [17]; (b) flattening of the head of the
femur especially at the medial part, dysplasia of the acetabulum by an apparently
abnormal teardrop configuration of the medial acetabular wall (Fig. 2); (c) small
epiphyses of proximal and distal femur and proximal tibia with or without flattened
condyles of the knees and a shallow intercondylar notch; and (d) a symmetrical
distribution of abnormalities. Subjects fulfilling the first, second, and fourth
criterion (minimal diagnostic criteria) were regarded as radiologically affected.
Patients not fulfilling these criteria were classified as radiologically unaffected. 
One of the two index patients of the publication by Elsbach had died before the
re-examination (Fig. 1, IV-26). This was the only patient we regarded as affected
on the basis of the clinical and radiological description by Elsbach only. 
Genetic examination. We used all members of the family for whom DNA was
available. 
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RESULTS
Pedigree. The updated pedigree (Fig. 1) shows only those subjects of whom
information about the phenotype was available.
In 6 successive generations, 15 subjects were clinically and/or radiologically
affected. The male/female ratio among patients was close to 1. This pattern of
familial occurrence and possibly one male to male transmission (II-1III-2)
suggest an autosomal dominant mode of inheritance. All subjects with an affected
parent and at least one affected child, and who had been examined clinically and
radiologically, showed clinical expression, suggesting that at adult age the
penetrance of the gene defect is high.
Clinical findings. Six men – five according to the clinical criteria, and one on
the basis of Elsbach’s description [5] – and eight women were classified as
clinically affected (group I); for one male and one female at 50% prior risk, the
clinical affection status was inconclusive (group II), whereas in two men and eight
women at 50% prior risk, the diagnosis of BHMED was clinically excluded (group
III) (Table I). 
Table I. Summary of clinical affection status.
Clinical category Male Female Total
Group I (Affected) 6   8 14
Group II (Inconclusive) 1   1   2
Group III (Unaffected) 2   8 10
Total 9 17 26
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Table II.  Summary of radiological versus clinical affection status.
Radiological affection Clinical affection status
Affected Unaffected Doubtful Unknown Total
Affected 13   - - 2* 15
Unaffected   1   9 - - 10
Doubtful**   -   - 1 -   1
Unknown**   -   1 1 -   2
Total 14 10 2 2 28
* This table includes two patients with radiographs previously published by Elsbach (1959) [5] but
without clinical re-examination in the current study.
** Inconclusive is split up into doubtful and not known (see section methods/diagnostic criteria).
The clinically affected subjects (group I) clearly showed reduced femur
abduction (limited with an average of 15°) and internal rotation (limited with an
average of 25°) as compared to group III (unaffected), whereas group II
(inconclusive) is too small and heterogeneous for meaningful comparison. There
was no loss of knee mobility among patients of group I, although all persons
classified clinically as affected suffered from knee complaints. The mobility of the
shoulders was unlimited, even at older age, although they were painful above the
age of 50 in group I. The hands showed no malformations. However, a shortening
of the metacarpals (MC), especially of MC IV and V, became more apparent upon
clenching of the fists.
Radiological findings. The six men and eight women who were classified as
affected according to clinical criteria (group I) were also classified as affected
according to radiological criteria, except one. This woman fulfilled the clinical
diagnostic criteria, but the radiographs were considered normal (Table II). The
remaining three men and nine women were radiologically classified as unaffected
or inconclusive.
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The hip joint showed a valgus angle of the femoral neck which is short and
thickened, flattening of the head of the femur especially at the medial part, and a
dysplasia of the acetabulum by an apparently abnormal teardrop configuration of
the medial acetabular wall (Fig. 2).
Additional radiographic features observed more than once among persons
classified as radiologically affected were a shallow intercondylar notch on the AP
view (Fig. 3A) and small epiphyses and flattened condyles on the lateral view of
the knee (Fig. 3B). In a  few  cases  the lateral femoral condyle showed  a  focus of
osteochondritis dissecans or an ulcus. Radiographs of the wrist from affected
relatives showed an ‘ulna plus’ with slight radial drift of the carpus and flattening
Figure 2. AP-radiograph of the pelvis and hips of a BHMED patient (IV-15).
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of the ulnar part of the radial epiphysis (Fig. 4). The spine showed signs of lumbar
spondylosis, whereas the cervical and thoracic part of the spine was normal.
Flattened vertebrae, such as occur in e.g. spondylo-epiphyseal dysplasia [6], were
not observed.
Body measurements. Patients who were classified as clinically and
radiologically affected had a lower mean total body height (TBH) in comparison
with unaffected first-degree relatives (Table III). However, the difference was
larger when the affected persons were compared with controls from the out-
patients clinic or with the reference population. Compared to controls, also the
unaffected first-degree relatives of BHMED patients showed a lower total body
height. Among men, a similar trend is observed for sitting height and span width. 
Figure 3. Radiographs of the right knee of a BHMED patient (III-2)
(Fig. 3A, lateral view; Fig. 3B, AP view).
a b
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In turn, also unaffected first-degree relatives of patients showed a reduced total
body height as compared to the general population, matched for age and gender. 
Laboratory data. Available results from additional laboratory measurements
including calcium, phosphate and alkaline phosphatase levels in serum were within
the normal ranges.
Figure 4. PA-radiograph of the wrist (IV-3) with an ‘ulna plus’ with slight radial
drift of the carpus and flattening of the ulnar part of the radial epiphysis.
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DISCUSSION
In this study we analysed the clinical and radiological features of a skeletal
dysplasia previously described by Elsbach in 1959. Elsbach allocated the name
bilateral hereditary micro-epiphyseal dysplasia (BHMED) to this condition [5].
Some authors [1,13] argued that this family might be classified as a type of
multiple epiphyseal dysplasia (MED). Others [12] classified it as a form of
osteopetrosis with precocious manifestations. We found the clinical picture in this
family and especially the radiological features consistently different from MED
and to be unique in its presentation. The onset of complaints in this family was at
about four years of age as compared to at about ten years in MED. In both
disorders, complaints start in early childhood and stabilise during adolescence. In
adulthood, complaints in BHMED worsen due to early-onset osteoarthritis. In the
Elsbach family, mainly the hip and knee joint were bilaterally affected and
harmful, whereas in MED also the elbow and ankle are involved [15]. Affected
BHMED-individuals had a small total body height, but with an apparently
proportionate build. The gait was waddling. The affected individuals had a smaller
total body height than unaffected first-degree relatives. In turn, these unaffected
relatives showed a smaller total body height than controls. In addition, the total
body height of spouses of affected subjects was remarkably reduced compared to
the control group and the reference population. Thus, this indicates that the short
stature of offspring of affected patients can not only be attributed to the putative
dominant mutation causing BHMED, but might also be the result of (epi-)genetic
factors that play a role through height-related partner selection [9,16]. Furthermore,
it shows that total body height is not a distinctive inclusion criterion when defining
the affection status in a skeletal dysplasia with mild to moderate effect on final
adult height. 
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Both BHMED and MED show an autosomal dominant mode of inheritance with
a gender ratio of about 1. Radiographically, in BHMED the epiphyses of the
proximal and distal femur and proximal (and distal) tibia appear rather late in
comparison with their peers with subsequent flattening in the following years.
Initially, during childhood, the epiphyses of the knee are irregular. In adolescence,
the knee epiphyses show a more continuous aspect without irregularities. Only the
joint surface is flattened, especially at the lateral condyle. Fairbanks described
MED in 1935 [7] and gave a further delineation in 1947 [6]. In some cases the
disease was familial. Short hands with brachydactyly, characteristic for MED
[11,15] were not reported in BHMED. In the family described here, we found
shortening of MC IV and V. In children with MED, a deficiency of the lateral part
of the distal ossification centre of the tibia is observed, evolving into in a sloping
end of the tibia at adulthood [11]. In contrast, in BHMED the distal tibia epiphysis
is only small in size.
Other conditions with partial resemblance of epiphyseal ossification
disturbances are mucopolysaccharidosis IV (M. Morquio-Brailsford, MPS-IV) and
disorders characterised by punctuated chondrodysplasia. In BHMED some
stippling on the periphery of the epiphyses (a sign of multiple ossification centres)
may be observed, but never as prominent as in chondrodysplasia punctata [14]. In
MPS-IV, epiphyseal dystrophy is found with typical changes in the spinal column
and in most centres of ossification, especially of the hip. In contrast with BHMED,
the acetabula are enlarged [10]. Furthermore, the mode of inheritance for both
chondrodysplasia puncatata and MPS-IV is autosomal recessive, which clearly
differentiates these conditions from BHMED.  
The patient with radiological signs of a bilateral epiphysiolysis of the hip (III-
5), was a coincidental finding without signs of BHMED.
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The clinical features in this family with BHMED represent a consistent and distinct
phenotype with multiple differences in comparison with MED. Therefore, BHMED
possibly represents a specific skeletal dysplasia due to a unique genetic defect. 
Future linkage analysis and characterisation of the molecular defect causing this
disorder will clarify whether it is indeed allelic to other skeletal dysplasias like
MED, or due to a mutation of a novel gene. This study demonstrates that BHMED
as a distinct entity to be separated from classical MED. A dysfunction of the
epiphyseal chondrocyte with subsequent delayed and irregular ossification might
be the pathogenic basis of BHMED. Epiphyseal irregularity, together with the
morphoplastic influence of both articular surfaces probably counts for the
dyscongruence and secondary osteoarthritis.
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ABSTRACT
Aim of the study: to prove that bilateral hereditary micro-epiphyseal dysplasia
(BHMED), first described by Elsbach in 1959 [1], is a distinct disorder radiologi-
cally as well as clinically, compared with multiple epiphyseal dysplasia (MED).
Materials and methods: we used the data of the revised pedigree with 84
family members, performed a medical history, physical examination and made a
radiological evaluation for making a clinical and radiological phenotype of
BHMED family members. We used blood samples for genetic analysis.
Results: although there is a clear clinical picture of the dysplasia, the
radiological signs are more reliable at making the diagnosis. Especially the typical
deformity of the hip and knee joint are diagnostic for BHMED. By linkage analysis
we excluded linkage with the three known MED-loci (EDM1, EDM2 and EDM3).
Conclusion: BHMED is indeed an entity that is distinct from common multiple
epiphyseal dysplasia (MED), clinically, as well as radiologically as well as
genetically.
INTRODUCTION
Bilateral hereditary micro-epiphyseal dysplasia (BHMED) is a rare skeletal
dysplasia, in which predominantly the hips and knees are affected. In 1959,
Elsbach gave the first description of an unique Dutch family with this disorder [1].
The radiological observation of small epiphyses in hip, knee and shoulder urged
him to designate the disorder as BHMED. The affected joints are involved
simultaneously and bilaterally. The pedigree of this family was revised and
RADIOLOGICAL FEATURES OF BHMED
___________________________________________________________________
74
updated. This enabled us to further delineate the clinical and especially the
radiological phenotype.
To establish that BHMED is indeed a clinical and radiological other dysplasia
than the well known MED, we performed a linkage analysis. For multiple
epiphyseal dysplasia (MED) three genetic loci (EDM1, EDM2 and EDM3) have
been identified on chromosomes 19p13.1, 1p33-p32.2 and 20q13.3, respectively.
EDM1 is associated with mutations in the cartilage oligometric matrix protein
(COMP), EDM2 is associated with mutation in the alpha-2 chain of type IX
collagen (COL9A2) and EDM3 is associated with mutations in the alpha-3 chain
type IX collagen (COL9A3). No evidence for linkage of BHMED in this family
was found to any of the three currently known MED loci. 
MATERIAL AND METHODS
After informed consent, from each family member a medical history was taken
according to a standardised protocol. The family exists of 84 members in six
generations of which 44 were clinically relevant. Physical examination was done
according to the guidelines for the Evaluation of Permanent Impairment (4th
edition) of the American Medical Association [2].
For the clinical diagnosis of BHMED, we used the clinical description
according to Elsbach [1], i.e., bilateral simultaneous onset of complaints of pain in
hip and knee joints, an apparently short stature, and in addition waddling gait and
restricted range of motion of the hip. Persons younger than four years of age were
excluded from this study, since onset of complaints was rarely if ever before this
age. Patients and relatives with these clinical symptoms were categorised as
affected. Persons who did not fulfil these clinical symptoms, or who were not
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examined or only incompletely examined were categorised as inconclusive with
respect to affection status. Only patients who underwent a complete examination
and showed no clinical signs of BHMED were categorised as clinically unaffected.
Roentgenographs made in the past were retrieved and supplemented with new ones
when clinically indicated. For radiological description of the state of affectedness,
all roentgenographs were reviewed by a radiologist specialised in skeletal
dysplasias (P.F.D.), without prior knowledge of the clinical and pedigree
information.
We also measured the width of both condyles (X) and the height of the
intercondylar notch (Y) on the plain antero-posterior (AP) film. In a standardised
way and only with a fully extended lower extremity, an X/Y ratio was computed as
an indirect but quantifiable measure of the severity of the dysplasia, as shown in
figure 2.
In affected family members, routine laboratory examination was done. Blood
samples were taken for DNA extraction. 
Polymorphic markers flanking the COMP gene (D19S226 and D19S414), the
COL9A2 gene (D1S255 and D1S2797) and the COL9A3 gene (D20S196,
D20S100 and D20S173) were used to test for linkage to any of these three loci. We
used a highly conservative genetic model for our linkage analysis; BHMED was
assumed to be an autosomal dominant disorder with a gene frequency of 1:1000
with full penetrance. 
DNA was available from 22 family members: 12 affected family members (III-
2, III-23, III-27, IV-3, IV-15, IV-18, IV-21, IV-28, V-1, V-4, V-5 and V-6), eight
unaffected family members (III-5, III-8, III-9, III-29, IV-19, IV-23, IV-25 and V-
13) and of two healthy spouses who had affected offspring (III-22 and IV-14),
according to the pedigree (Fig. 1). Family members who were radiologically
affected (II-1 and II-6) or affected  according  to Elsbach as indicated in the current
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pedigree (I-1, III-14 and III-21) (Fig. 1) were also classified as affected in the
linkage analysis.
RESULTS
Pedigree. The current pedigree (Fig.1) encompasses 6 generations and shows
an apparently autosomal dominant mode of inheritance with a male/female gender
ratio of affected persons close to unity. All subjects who had an affected parent and
at least one affected child, showed clinical and radiological symptoms of BHMED.
This suggests that at adult age the penetrance of the gene defect is high. In
comparison with the pedigree published by Elsbach [1], the pedigree is extended
with subsequent generations. In addition, one branch of the family appeared to be
clinically and radiologically unaffected whereas Elsbach supposed them to be
affected.
Figure 2. Measurement of the
dysplasia of the knee by the X/Y
ratio of the width of the condyles
(X) relative to the height of the
intercondylar notch (Y).
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Physical examination. In general, the clinical picture of an affected BHMED
family member showed a short stature and a waddling gate with limping. There
was a loss of hip function, especially in the abduction (limited with an average of
20 degrees) and in the internal rotation (limited with an average of 25 degrees).
Only above the age of 60, there were flexion-contractures of the knee. The
shoulders showed no limitation of function, even at older age, although they were
painful in movements above the age of 50 in the affected. The hands appeared to be
relatively broad and short. When clenching the fists, a shortening of the
metacarpals (MC), especially MC IV and V was noticed. In some subjects, the feet
showed a slight proximal syndactyly at the second webspace.
Figure 3. Pelvis of a 45-year-old woman with BHMED, showing a valgus angle of
the femoral neck which is short and thickened, flattening of the head of the femur
and the femoral epiphysis. Remark the interesting teardrop configuration in the
acetabulum.
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Table I. Summary of radiological observations (N of abnormal dysplastic joints / N of
radiologically evaluated joints of affected and unaffected subjects).
N = 28 Shoulders Elbows Wrists Spine Hips Knees Ankles
Small epiphyses 6/12 1/1 15/28 2/5
Small epicondyles 1/1 15/28
Ulna plus 11/15
Spondylosis 7/7
Flattened head 15/28
Short valgus neck 15/28
Shallow notch 15/28
Despite the high rate of complaints of low back pain, physical examination
showed no abnormalities, except for lumbosacral fixation in some subjects.
Radiological examination: Radiographic evaluation was possible in twenty-
eight family members (Table I).
Hip abnormalities (Fig. 3) were characterised by a valgus angle of the femoral
neck [3] which is short and thickened [4], flattening of the head of the femur and
the femoral epiphysis especially at the medial part – at the site of the fovea
centralis – , and dysplasia of the acetabulum as expressed by a lack of development
of the normal teardrop configuration of the medial acetabular wall. 
The abnormalities of the knee were characterised by dysplastic deformities like
flattened and small condyles (Fig. 4a,b), especially on the lateral view in contrast
with unaffected family members. In a few cases there was a focus of osteo-
chondritis dissecans and in others an ulcus was seen at the lateral femoral condyle.
Table II. The intercondylar notch X/Y ratio.
N = 28 Notch X/Y ratio (range)
Affected     (n = 15 ) 12.17       (9.29 – 15.13)
Unaffected (n = 13 )   9.75       (7.15 – 12.10)
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Figure 4. (a) AP-view of the left knee of
a 42-year-old man with BHMED,
showing the flattened and small
condyles, and the shallow intercondylar
notch. (b) Lateral view of the same left
knee (a), showing the small epiphyses
and small condyles. (c). MRI of the
same left knee (b), showing an irregular
thickness of the cartilage cover.
(conventional gradient echo-pulse
sequence, T2* weighting, small flip
angle 5˚–20˚, long TE 15–25 ms, short
TR).
a b
c
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All affected family members showed a shallow intercondylar notch on the AP view
of the knee compared to the unaffected family-members. As shown in figure 2, the
X-value represents the width of both condyles and the Y-value represents the
height of the intercondylar notch. For affected and unaffected family members, the
ratio between the width of the condyles (X) and height of the intercondylar notch
(Y) is given in Table II. 
The facies patellaris of the distal femur was not flattened on the axial patellar
view.
Figure 5. PA-view of both hands (and wrists) of an affected 52-year-old woman,
showing an ‘ulna plus’ with slight radial drift of the carpus and flattening of the
ulnar part of the radial epiphysis. The hands show short metacarpals of the fourth and
fifth digits, but also a shortening of the proximal and midphalanges. The distal
phalanges showed normal lengths.
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In some affected family members additional magnetic resonance imaging of the
knees was performed, showing an irregular thickness of the cartilage cover (Fig.
4c).
In all affected family members an ‘ulna plus’ with slight radial drift of the
carpus and flattening of the ulnar part of the radial epiphysis was observed. X-rays
of the hands showed short metacarpals of the fourth and fifth digits, but also a
shortening of the proximal and midphalanges. The distal phalanges showed normal
lengths (Fig. 5).
The humeral head showed a small and flattened epiphysis and a shallow glenoid
surface with premature osteoarthritis above the age of 50 (Fig. 6).
Figure 6. AP-view of both shoulders of a 73-year-old woman having BHMED,
showing the small and flattened epiphysis and a shallow glenoid surface with
premature osteoarthritis.
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Radiologically, the spine showed only signs of lumbar spondylosis, whereas the
cervico-thoracic spine was normal. Flattened vertebrae as occur in e.g. spondylo-
epiphyseal dysplasia [5], were not observed.
From three clinically and radiologically affected persons, radiographs of the
whole upper and lower extremity were available. Although there were no or minor
complaints of elbow and ankle joints, the X-rays of the separate joints showed
small epiphyses of distal humerus and distal tibia.
In summary, affected joints were characterized by small epiphyses without
involvement of the metaphyses.
Laboratory examination. The routine laboratory examination in affected
family members showed normal results, ruling out a number of metabolic bone
disorders.
Table III. Two point LOD scores between BHMED and markers flanking the EDM1-3
loci.
Recombination fractions (cM)
Marker 0 0.01 0.05 0.10 0.20 0.30 0.40
D19S226 -  -1.61 -0.93 -0.62 -0.30 -0.12 -0.03
D19S414 -  -1.01 -0.41 -0.22 -0.07 -0.03 -0.05
D1S255 -  -3.12 -1.49 -0.81 -0.28 -0.10 -0.03
D1S2797 -  -5.73 -3.01 -1.90 -0.90 -0.41 -0.14
D20S196 -  -9.27 -4.59 -2.73 -1.15 -0.47 -0.16
D20S100 -  -7.01 -3.58 -2.16 -0.90 -0.33 -0.07
D20S173 -  -7.90 -3.91 -2.34 -0.99 -0.39 -0.10
The currently known gene loci of EDM1-3 (D19, D1, D20) show very low LOD-scores,
showing that BHMED can be excluded as being one of the EDM1-3 dysplasias.
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Genetic examination. Table III summarises the results of linkage analysis
showing no evidence for linkage of BHMED in this family to any of the three
currently known MED loci (EDM1, EDM2 and EDM3). Most of the tested markers
provided strong evidence for non-linkage.
DISCUSSION
At the moment, more than 190 skeletal dysplasias are known, divided in 32
groups [6].
We re-examined the family initially studied by Elsbach. We found strong
clinical, radiological, and molecular genetic support for his assumption that the
skeletal disorder in this family represents a unique clinical entity, that has to be
distinguished from common MED. Radiological evaluation of the joints involved
in BHMED showed a unique pattern of abnormalities. The morphogenesis of the
joints is disturbed, as is seen in the flattened dysplastic femoral head with its small
epiphyses and the likewise dysplastic acetabulum. The same pattern is seen in the
knee joint, at the femoro-tibial site as well as at the patellar-femoral site, of which
the shallow intercondylar notch is an additional sign. The facies patellaris of the
distal femur seems to be less flattened, especially seen on the axial view.
Due to the deformed joint surface, early onset osteoarthritis seemed to be
induced, as was observed in many family members.
There was only a general shortening of the long bones, due to affected proximal
and distal epiphyses. Predominantly rhizomelic or mesomelic deformities,
proximal focal femoral deficiency and other syndromes could be ruled out in this
way.
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The width of the condyles (X) relative to the height of the intercondylar notch
(Y) showed indeed a clear difference between family members with BHMED and
unaffected relatives (Table II). However, the X/Y ratio showed wide overlapping
values for the two groups of affected and unaffected subjects and this limits its
diagnostic value. Furthermore, this ratio does not reflect the irregularities of the
cartilage as can be visualised with MRI (Fig. 4c).
Once Elsbach published his description of the disorder in this family, some
authors [7,8] suggested that BHMED was in fact a variant of MED, and not a
distinct clinical entity.
We re-examined this family to delineate further the clinical picture and to
establish whether BHMED is a variant of or identical to MED or indeed, as
suggested by Elsbach, a distinct clinical entity.
In the ‘Elsbach family’, the well-developed ossification centre of the epiphyses
are small and homogeneous, whereas in MED accessory ossification centres are
seen, scattered in the periphery of the cartilaginous epiphyses. The metacarpals and
phalanges of affected relatives were short, but the distal phalanges were not stubby
as in MED [9]. Although affected subjects showed deformity of the ulnar part of
the distal radial epiphysis, the ‘V’ wrist joint deformity [10] due to hypoplasia of
the adjacent portions of the radial and ulnar epiphyses in MED, was not observed
in the currently studied family. In addition, the carpal bones were of normal size
without irregularities, whereas they are small and irregular in MED.
In the ‘Elsbach family’, the spine is not involved, neither clinically nor
radiologically. In MED, the spine shows minimal flattening and reduction of the
vertebral bodies, but vertebral changes may be quite similar to Scheuermann’s
disease because of the intraspongious herniations of the lower thoracic or first
lumbar vertebrae. With the appearance of the apophyses, the rim of the vertebral
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body shows fragmentation in MED and, infrequently, a vertebral body will be
fragmented [11].
Other signs like ‘slant sign’ of the ankle (thinning of the lateral part of the lower
tibial epiphyses), ‘flat-top’ talus, and early onset osteoarthritis were non-specific
for the distinction of different dysplasias. In particular, these features do not
provide further distinction between these conditions, because they were observed at
low frequency in both, or because of low denominator for each type of joints
studied.
In the ‘Elsbach family’ the femoral head is medially flattened in each affected
relative, whereas in MED a large variation of abnormalities may be observed
ranging from normal to gross deformation [12].
With linkage analysis, the three currently known loci for MED (EDM1, EDM2
and EDM3) were excluded as candidate genes for BHMED. This supports that
BHMED represents an unique entity which is distinct from common MED. Future
linkage analysis and mutation analysis of positional and functional candidate genes
should reveal whether BHMED is allelic to another skeletal dysplasia or due to a
mutation in a novel gene.
CONCLUSION
Bilateral hereditary micro-epiphyseal dysplasia (BHMED) is a separate entity in
the list of the epiphyseal skeletal dysplasias. Although there is a clear clinical
picture of the dysplasia, the distinctive radiological signs are more reliable for
making the diagnosis in new patients. Especially the typical deformity of the hip
and knee joint, that appear symmetrically and simultaneously, are diagnostic for
having BHMED. By linkage analysis we could exclude that BHMED is a form or
variant of common multiple epiphyseal dysplasia (MED).
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ABSTRACT
In this study, we followed-up the family with bilateral hereditary micro-
epiphyseal dysplasia (BHMED) originally described by Elsbach in 1959. Clinical
re-examination of all available family members resulted in further delineation of
the clinical and radiological phenotype, which is distinct from common multiple
epiphyseal dysplasia (MED). Linkage analysis excluded EDM1, EDM2 and EDM3
as candidate genes. Linkage and mutation analysis of matrilin-3 revealed a new
pathogenic mutation confirming that BHMED is indeed a distinct disease entity
among MED and MED-like disorders.
INTRODUCTION
Bilateral hereditary micro-epiphyseal dysplasia (BHMED) is a rare, usually
symmetrical skeletal dysplasia first reported by Elsbach [1959]. In the family he
described, several members complained mainly of pain in hips and knees from
early childhood. Because of the radiological finding of small epiphyses in the hip
and knee joint, Elsbach designated the disorder bilateral hereditary micro-
epiphyseal dysplasia. BHMED should be differentiated from multiple epiphyseal
dysplasia (MED). Recently, several members of the original family were referred
to the Department of Orthopaedic Surgery in Delft with questions about the genetic
background, and the recurrence risk. We re-examined the extended family, in order
to evaluate diagnostic criteria and the clinical course, to determine the clinical
spectrum, and to provide tools for the diagnosis of possibly affected persons with
only partial expression of the disease.
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By mutation analysis we identified a pathogenic mutation within the matrilin-3
gene in our family.
This study illustrates the value of detailed and accurate description of the
phenotype as a basis for clinical follow-up studies and future genetic studies, and
further delineates the clinical spectrum of matrilin-3 related disorders.
MATERIALS AND METHODS
The pedigree was updated and contained 54 subjects in six generations. Thirty-
two members of the family and 12 spouses were examined by the first author
(A.K.M.). After informed consent, all family members agreed to full cooperation
with the study. This study was approved by the Medical Ethics Committee of the
Reinier de Graaf  Hospital in Delft, the Netherlands.
A full medical history was taken according to a standardized questionnaire.
Physical examination was performed according to a standard protocol. The range
of motion of hip, knee, and shoulder joints was measured according to guidelines
(4th edition) of the American Medical Association (Doege et al., 1993). Total body
height, sitting height, leg length, and span width were measured and compared with
reference data from the Dutch population (CBS, 1998).
Prior and additional radiographs of first- and second-degree family members
with complaints were evaluated by one of the authors (P.F.D.). In some of the
cases, results of laboratory tests of serum calcium, phosphate and alkaline
phosphatase levels were available and collected.
Diagnostic criteria. All subjects over 4 years old were classified clinically and
radiologically as affected, unaffected, or inconclusive (included not known).
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Clinical classification. The original clinical description by Elsbach [1959] was
used as the basis for the clinical diagnosis of BHMED. Diagnostic criteria were
bilateral simultaneous onset of pain in hip and knee joints, short stature, waddling
gait and restricted range of motion of the hip. Patients and relatives who fulfilled
all clinical diagnostic criteria were categorised as affected (group I). Subjects who
did not fulfil all diagnostic criteria or who were not examined or only incompletely
examined were categorized as inconclusive with respect to clinical affection status
(group II). Patients who showed no clinical signs of BHMED were categorized as
unaffected (group III). 
Radiological classification. All radiographs were reviewed by a radiologist
specialized in skeletal dysplasias (P.F.D.), without knowledge of the clinical
evaluation or the a priori risk for the condition. The diagnostic criteria for
radiological status were (a) a hip characterized by valgus angle of the femoral neck
(Hegenbarth, 1980) which is short and thickened (Stevens et al., 1985); (b)
flattening of the head of the femur especially at the medial part, dysplasia of the
acetabulum by an apparently abnormal teardrop configuration of the medial
acetabular wall (Fig. 2); (c) small epiphyses of proximal and distal femur and
proximal tibia with or without flattened condyles of the knees and a shallow
intercondylar notch (Fig. 3); and (d) symmetrical distribution of abnormalities.
Subjects fulfilling the first, second, and fourth criteria (minimal diagnostic criteria)
were regarded as radiologically affected. Patients not fulfilling these criteria were
classified as radiologically unaffected. 
One of the two index patients in the publication by Elsbach [1959] died before
re-examination (Fig. 1, IV-26). This was the only patient we regarded as affected
solely on the basis of the clinical and radiological description by Elsbach. The
updated case history of the second index patient (Fig. 1, IV-28) is described in the
results.
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GENETIC ANALYSIS
Genetic studies. Genomic DNA was isolated from peripheral blood as described
(Miller et al., 1988). DNA was available from 12 affected family members (III-2,
III-23, III-27, IV-3, IV-15, IV-18, IV-21, IV-28, V-1, V-4, V-5 and V-6), eight
unaffected family members (III-5, III-8, III-9, III-29, IV-19, IV-23, IV-25 and
V-13) and of two healthy spouses who had affected offspring (III-22 and IV-14)
(Fig. 1). Family members who were radiologically affected (II-1, II-6) or affected
according to Elsbach as indicated in the current pedigree (I-1, III-14, III-21) (Fig.
1) were also classified as affected in the linkage analysis. Two point linkage
Figure 2. AP-radiograph of the pelvis and hips of a BHMED patient showing
flattening of the femoral head, a short and thickened femoral neck and an abnormal
teardrop configuration of the medial acetabular wall.
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analysis was done using the MLINK program of the LINKAGE package (version
5.1) (Lathrop et al., 1984). LOD and location scores were calculated assuming
BHMED to be an autosomal dominant disorder with 100% penetrance and a gene
frequency of 1:10,000. No phenocopies were allowed and allele frequencies were
calculated from the family. For multiple epiphyseal dysplasia, three genes (EDM1-
3) have been identified on chromosomes 19p13.1, 1p33-p32.2 and 20q13.3,
respectively. EDM1 is associated with mutations in the cartilage oligometric matrix
protein (COMP), EDM2 is associated with mutation in the alpha-2 chain of type IX
Collagen (COL9A2) and EDM3 is associated with mutations in the alpha-3 chain
type IX Collagen (COL9A3). Short tandem repeat polymorphisms (STRPs)
flanking the COMP gene (D19S226 and D19S414), the COL9A2 gene (D1S255
and D1S2797) and the COL9A3 gene (D20S196, D20S100 and D20S173) were
used to test for linkage to any of these three loci. 
For the systematic genome scan STRPs from the Marshfield screening set 6A
(http://research.marshfieldclinic.org/genetics/) were amplified using 25 ng genomic
DNA in 10 l PCR reactions containing 1X GeneAmp PCR Gold Buffer; 1.5 mM
MgCl2; 25 ng of fluorescent forward primer; 25 ng of unlabelled reverse primer
and 0.4 units of AmpliTaq Gold DNA polymerase (Applied Biosystems, Foster
City, CA, USA). Initial denaturation was 10 min at 94oC followed by 32 cycles of
30 s denaturation at 94oC, annealing at 55oC and 90 s extension at 72oC. PCR
products were loaded on an ABI3100 automated sequencer (filterset D), data were
analyzed using ABI GeneMapper 1.0 software. The genomic structure of matrilin-3
(MATN3) was determined by aligning cDNA (NM_002381) with genomic
sequence NT_005214. Primers were designed to amplify DNA from coding
regions, splice sites and at least 50 bases of flanking intronic sequence on both
sides of each exon. The used primers are listed in Table I.
CHAPTER 4.3
___________________________________________________________________
97
Table I. Used primers to amplify DNA from coding regions, splice sites.
Exon Forward Reverse Size
(bp)
1 cgcggacaaggctccttg ctcctcgttcgatgctcac 430
2_1 tcctggaatcccagagttc ctcattcacctggtcctg 472
2_2 tggacgaagccttcacagtg ctctgggtacacaatgtctg 347
3 cagagagcaatgtctattga tacaaagtatggaaataagctg 424
4 ataactgtaagtggcgtggc tcccagtcaatgtgacctgc 293
5 tttcctcatatgtttccagc gagcaatgtgtgccttcatc 371
6 gactactacattctcagcac cacaactgtgtcttagacag 331
7 cacttaggtaagtcttaacg tcacttgcctgtggaatgtc 316
8 ttcacttctcataggacata gaatcatgctgattctgcag 339
Figure 3. Radiographs of the left knee of a BHMED patient (Fig. 3a, AP-view; Fig. 3b,
lateral view) showing small epiphyses, a shallow intercondylar notch due to flattened
condyles and osteo-arthritic changes.
a b
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PCR reactions for exon 1 were performed in 25 l containing 10 X Cloned PFU
PCR buffer (Stratagene); 200 M dNTP; 1 M forward primer; 1 M reverse
primer; 1.25 units Cloned PFU polymerase (Stratagene, La Jolla, CA, USA) and 50
ng genomic DNA. Cycle conditions: 10 min at 98oC; 11 cycles of 30 s denaturation
at 98oC, 30 s annealing at 68–1oC per cycle, and 2 min extension at 75oC; followed
by 24 cycles of 30 s denaturation at 98oC, 30 s denaturation at 58oC and 2 min
extention at 75oC; final extension 5 min at 75oC. Exon 2_1 and exon 2_2 were
amplified in 50 l containing 10X PCR Gold buffer (Perkin Elmer Life Sciences
Inc., Boston, MA, USA); 1.0 mM MgCl2; 200 M dNTP; 0.8 M forward primer;
0.8 M reverse primer; 2.5 unit Ampli Taq Gold polymerase (Perkin Elmer Life
Sciences Inc.) and 50 ng genomic DNA. Exon 3, 4, 5, 6, 7 and 8 were amplified in
50 l containing 10X PCR Gold buffer (Perkin Elmer Life Sciences Inc.); 1.5 mM
MgCl2; 200 M dNTP; 0.8 M forward primer; 0.8 M reverse primer; 2.5 unit
Ampli Taq Gold polymerase (Perkin Elmer Life Sciences Inc.) and 50 ng genomic
DNA. Amplification was done using 7 min initial denaturation at 94oC; 35 cycles
30 s  at 94oC, annealing 30 s at 55oC (for exon 2_1), at 58°C (for exon 2_2, 4, 5, 6
and 7) or at 50°C (for exon 3 and 8), 1 min 30 s extension at 72oC; final extension
5 min at 72oC. PCR products were purified using the Millipore Multiscreen PCR
plates, and their approximate concentration was determined using Low DNA Mass
Ladder (GibcoBRL, Lifetechnologies, Rockville, USA). After direct sequencing of
both strands using BigDye Terminator chemistry Version 3 (Applied Biosystems);
Millipore Multiscreen-HV plates containing Sephadex G50 (Amersham
Biosciences AB, Uppsala, Sweden) were used to purify the sequenced PCR
products. Products were loaded on an ABI3100 automated sequencer and analysis
was done with SeqScape Version 1.0 for heterozygous base calls and sequence
alignment.
CHAPTER 4.3
___________________________________________________________________
99
Testing of the base changes/deletion in exon 2_1 in the family and 200 control
chromosomes was done using Allele Specific Oligo Hybridization (ASO). PCR
products containing exon 2_1 were blotted onto Hybond-N+ (Amersham
Biosciences). The blots were hybridized at 1 hour at 40oC in 5X SSPE; 1%SDS
and 0.05 mg/ml single strand salmon sperm DNA with either the normal
(gaactatgctagcac) or mutated (gaactatcctagcac) sequence primer.
Filters were washed until a final stringency of 0.3X SSC/0.1% SDS at 40oC.
RESULTS
Case history. Patient IV-28 (Fig. 1) was examined by Elsbach [1959] when he
was five years of age. At that age, he had a history of hip and knee complaints for
about one year, consisting of a limping and waddling gait, and difficulties in
running and climbing stairs. Abduction and internal rotation were reported to be
limited. At the age of 28, a total hip replacement was performed on the left side,
which was revised 3 and 4 years later. Despite an acetabulum enlargement on the
right side at 16 years, osteoarthritis developed and at 37 years that hip had to be
replaced as well. Two years later an open Neer-plasty of his non-dominant left
shoulder was performed because of complaints of impingement, although no
radiological signs of shoulder dysplasia existed. At the age of 34 years, arthroscopy
showed mild degeneration of the cartilage of the right knee. Nine years later a total
knee replacement followed on that side. Although this subject was the smallest in
height among his peers during primary school, he eventually reached a total body
height (TBH) of 1.71 m. (<15th centile for the reference population [CBS, 1998]).
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Table II. Summary of radiological versus clinical affection status.
Radiological affection Clinical affection status
status Affected (I) Inconclusive** (II) Unaffected (III) Total
(Group) Doubtful Unknown
Affected 13 – 2* – 15
Inconclusive**
– Doubtful – 1 – – 1
– Unknown – 1 – 1 2
Unaffected 1 – – 9 10
Total 14 2 2 10 28
*   This table includes two patients with radiographs previously published by Elsbach [1959] but without clinical 
  re-examination in the current study.
** Inconclusive is split up into doubtful and not known (see section methods/diagnostic criteria).
Pedigree. The updated pedigree (Fig. 1) shows only those subjects of whom
information about the phenotype was available. Elsbach (1959) reported one
branch of this family to be ‘certainly affected’, without any clinical description.
However, after re-examination of subject III-5, her offspring, and III-8, these
relatives were classified as clinically and radiologically unaffected with BHMED.
In 6 successive generations, 15 subjects were clinically and/or radiologically
affected, and the male/female ratio was close to 1. This pattern of familial
occurrence and possibly one occasion of male-to-male transmission (II-1III-2)
suggest an autosomal dominant mode of inheritance. All subjects with an affected
parent and at least one affected child, and who had been examined clinically and
radiologically, showed clinical expression, suggesting that at adult age the
penetrance of the gene defect is high.
Clinical findings. Six men – five according to the clinical criteria, and one on
the basis of Elsbach’s description [1959] – and eight women were classified as
clinically affected (group I); for one male and one female at 50% prior risk, the
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clinical status was inconclusive (group II), whereas in two men and eight women at
50% prior risk, the diagnosis of BHMED was clinically excluded (group III) (Table
II).
The clinically affected subjects (group I) clearly showed reduced femur
abduction and internal rotation compared to group III (unaffected), whereas group
II (inconclusive) is too small and heterogeneous for meaningful comparison.
Radiological findings. The six men and eight women who were classified as
affected according to clinical criteria (group I) were also classified as affected
according to radiological criteria, except one (Fig. 1, V-13). This woman fulfilled
the clinical diagnostic criteria, but the radiographs were considered normal (Table
II, lower left cell). The remaining three men and nine women were radiologically
classified as unaffected or inconclusive. Thus, none of the evaluated subjects were
classified as clinically unaffected and radiologically affected. Table III summarizes
the clinical and radiographic findings of affected persons, as well as the age and the
frequency of surgical interventions.
Routine laboratory data. Available results from additional laboratory
measurements including calcium, phosphate and alkaline phosphatase levels in
serum were within the normal ranges, according to the references of the
laboratories and hospitals involved.
Genetic analysis. Through linkage analysis the three currently known loci for
MED, EDM1-3, could be excluded as candidate genes for BHMED (Table IV).
In the systematic genome scan we obtained mildly positive LOD scores for
markers on chromosome 2. Testing additional markers in this region (Table V)
confirmed these findings and two-point linkage analysis yielded a maximum LOD
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score of Z = 5.20 at  = 0 for marker D2S220. Markers D2S2346 and D2S305 on
the centromeric side and D2S390 on the telomeric side were the first markers that
showed recombinations in the linkage analysis (pair-wise LOD score -). 
Table IV. Two point LOD scores between BHMED and markers flanking the EDM1, EDM2
and EDM3 loci.
Recombination fractions (cM)
Marker 0 0.01 0.05 0.10 0.20 0.30 0.40
D19S226 -  -1.61 -0.93 -0.62 -0.30 -0.12 -0.03
D19S414 -  -1.01 -0.41 -0.22 -0.07 -0.03 -0.05
D1S255 -  -3.12 -1.49 -0.81 -0.28 -0.10 -0.03
D1S2797 -  -5.73 -3.01 -1.90 -0.90 -0.41 -0.14
D20S196 -  -9.27 -4.59 -2.73 -1.15 -0.47 -0.16
D20S100 -  -7.01 -3.58 -2.16 -0.90 -0.33 -0.07
D20S173 -  -7.90 -3.91 -2.34 -0.99 -0.39 -0.10
Table III. Clinical and radiographic findings and surgical interventions for all affected
individuals.
N
(results/all affecteds)
Clinical and radiological symptoms
Limping/waddling gait 15/15
Limited hip-joint function 15/15
Early onset arthritis hip 15/15
Short MC IV & V 15/15
Small/irregular epiphyses 15/15
Coxa valga 15/15
Short thick femoral neck 15/15
Flattened femoral head 15/15
Shallow notch knee 15/15
Surgical procedures
Total hip replacement (THR) 9/15
Total knee replacement (TKR) 5/15
Acetabular shelf procedure (ASP) 4/15
Arthroscopy knee 4/15
Neer-plasty shoulder 4/15
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Table V. Pairwise LOD score at various recombination fractions between BHMED and
markers on chromosome 2p.
Recombinant fractions (cM)
Marker 0 0.01 0.05 0.1 0.2 0.3 0.4
D2S2346 -  0.75 1.81 1.97 1.66 1.05 0.39
D2S305 -  1.53 1.92 1.83 1.32 0.75 0.31
D2S2150 2.19 2.18 2.10 1.95 1.57 1.11 0.58
D2S220 5.20 5.12 4.76 4.30 3.28 2.15 0.93
D2S2221 3.91 3.84 3.55 3.17 2.38 1.53 0.65
D2S73 2.58 2.55 2.39 2.19 1.75 1.25 0.67
D2S390 -  -0.50 0.61 0.84 0.64 0.13 -0.25
D2S146 0.84 0.82 0.76 0.68 0.52 0.37 0.20
Recently, mutations in the matrilin-3 (MATN-3) gene were identified in patients
with MED (Chapman et al., 2001). This gene maps within the genetic interval
determined by the linkage study of this family. After determining the intron-exon
Figure 4. Sequence
electropherograms of
mutations found in
BHMED. Both normal
(left) and mutated (right)
and amino acid sequen-
ces are shown. Right:
The hetero-zygous base
change G382C in exon 2
resulting in an amino
acid substitution of
alanine to proline at
codon 128 (A128P).
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boundaries of the MATN-3 gene, using available sequence databases, the coding
region including intron-exon boundaries was sequenced on genomic DNA in a
patient and an unaffected individual from the family.
We detected a heterozygous base change, G382C in exon 2, from the coding
region (reference sequence XM_048680) resulting in an amino acid substitution of
an alanine to a proline A128P at codon 128 (A128P) (Fig. 4). Allele Specific Oligo
Hybridization (ASO) confirmed this mutation (Fig. 5). The mutation occurred in a
domain which is highly conserved through a number of different species. That the
Figure 5. Results of the allele specific oligohybridization (ASO) for the heterozygous
base change, G382C in exon 2, from the coding region (reference sequence XM_048680)
resulting in an amino acid substitution of an alanine to a proline A128P at codon 128
(A128P). The three colums on the left are the results of the hybridization with the ‘wild-
type’ oligonucleotide. The three colums on the right are the results of the hybridization
with the mutant oligonucleotide. Each dot represents a hybridization signal of  a DNA
sample. Inividual numbers given on the left of each dot and correspondent with the
number given in figure 1. Each individual carried  at least one normal allele and all
affected individuals also carried a mutant allele (the three rows on the left).
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human sequence of alanine 128 is indeed a conserved amino acid in humans
compared with animals is shown in figure 6,  in which the mutations identified to
date in the MATNs is pointed out. In addition, the mutation segregated with the
disease all available diagnosed relatives, and was not seen in 187 control
chromosomes from the general Dutch population.
DISCUSSION
In this study we analyzed the genetic, clinical and radiological features of a
skeletal dysplasia previously described by Elsbach in 1959. Elsbach allocated the
name bilateral hereditary micro-epiphyseal dysplasia (BHMED) to this condition
(Elsbach, 1959). Some authors (Bailey, 1973; McKusick, 1992) argued that this
family might be classified as a type of multiple epiphyseal dysplasia (MED). We
found the clinical picture in this family and especially the radiological features
consistently different from common MED and to be unique in its presentation. To
Figure 6. Comparison between the human sequence of alanine 128 and that of two other
species, house mouse and domestic chicken, shows that alanine 128 is a conserved amino
acid along with the mutations in the MATNs identified to date.
111 DTLDIGPADTRVAVVNYASTVKIEFQLQAY 140 matrilin-3 Homo sapiens
106 DTLDIGATDTRVAVVNYASTVKIEFQLNTY 135 matrilin-3 Mus musculus
82 DTLDVGERTTRVAVMNYASTVKVEFPLRTY 111 matrilin-3 Gallus gallus
69 ESLDVGPNATRVGMVNYASTVKQEFSLRAH 98 matrilin-1 Homo sapiens
73 ESLDVGPNATRVGLVNYASTVKPEFPLRAH 102 matrilin-1 Mus musculus
69 EGLDVGPNSTRVGVINYASAVKNEFSLKTH 96 matrilin-1 Gallus gallus
87 QFLDIGPDVTRVGLLQYGSTVKNEFSLKTF 114 matrilin-2 Homo sapiens
64 RGLNVGPNATRVGVIQYSSQVQSVFPLRAF 91 matrilin-4 Homo sapiens
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date, four different genes have been identified in autosomal dominant variants of
MED: EDM1 on chromosome 19p13.1, EDM2 on 1p33-p32.2, EDM3 on 20q13.3
and MATN-3 on 2p24-p23 (Chapman et al., 2001; Mortier et al., 2001). An
autosomal recessive form of MED (EDM4) is localized on chromosome 5q32-
q33.1 and was excluded because of a different mode of inheritance.
Our study confirms the role of MATN-3 in autosomal dominant MED-like
skeletal dysplasia as suggested by Chapman (2001) and Mortier (2001). The 4-
generation family they described briefly, showed slightly different abnormalities.
In the pelvis of some patients, the hip was only unilaterally involved. In our 6-
generation BHMED family, all affected joints are bilaterally involved. In EDM3,
Paassilta et al. (1999) described a family without complaints of hip and knee, and
Bönneman et al. (2000) described a family without complaints of the hip, but
predominantly of the knee, whereas there was no limitation of joint function or
radiological abnormality of hip and knee.
In these EDM3 families, myopathy and weakness of the lower leg,
characterized by the Gower-sign, was reported.
In EDM1 and EDM2, several authors (Oehlmann et al., 1994; Deere et al.,
1995; Briggs et al., 1995; Ballo et al., 1997; Ikegawa et al., 1998) described
radiological abnormalities of the spine, mostly the lumbar spine.
Recently, a new mutation is described in the collagen IX gene, COL9A1, which
codes for the alpha 1 (IX) chain. The results of this study show that mutations in
COL9A1 can cause MED, but they also suggest that mutations in COL9A1,
COL9A2, COL9A3, COMP and DTDST are not the major causes of MED and that
there exists at least one additional locus (Czarny-Ratajczak et al., 2001).
In all these types of EDM, complaints start in early childhood and stabilize
during adolescence. In adulthood, complaints in BHMED worsen due to early-
onset osteoarthritis. In the Elsbach family, mainly the hip and knee joint were
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bilaterally affected and painful, whereas in EDM3 also the elbow and ankle are
clinically involved (Bönneman et al., 2000). Affected BHMED-individuals had a
proportionally reduced total body height. The affected individuals had a smaller
total body height than unaffected first-degree relatives. However, unaffected first-
degree relatives in this BHMED family also had lower than average total body
height which is most probably due to (epi-)genetic factors like height-related
partner selection (Hensley 1994; Roscoe et al., 1987; Mostert et al., 2002b).
Brachydactyly is most characteristic of the autosomal recessive form of MED
(EDM4) (Gamboa and Lisker, 1974; Superti-Furga et al., 1999). Short hands with
brachydactyly, as often seen in EDM1 and EDM2 (Oehlmann et al., 1994; Briggs
et al., 1995; Leeds, 1960; Mourik van et al., 1993) were not reported in BHMED.
In the family described here, we found disproportionally shortened MC IV and V
(Mostert et al., 2002a).
The clinical features in this family with BHMED represent a consistent and
distinct phenotype with differences in comparison with a number of other EDMs. 
The finding of a pathogenic mutation in MATN-3, which completely segregated
with the clinically affected status, demonstrates that BHMED is indeed a variant of
MED. The position of the mutation found in this family (A128P) is within the
vWFA domain of MATN-3. The alanine residue at this position is conserved in
other species. The other mutations so far described are located within the same
domain (V194D and R121D). The function of the vWFA domain is largely
unknown but there is evidence that the metal ion-dependent adhesion site motif of
the equivalent vWFA domain of matrilin-1 associates with the ECM network
(Chen et al., 1999).
In this study, we confirmed that BHMED originally described by Elsbach in
1959 is indeed a distinct clinical entity by means of a pathogenic matrilin-3
mutation in addition to extensive clinical and radiological examination. Further
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studies are needed in order to explore the complete phenotypic spectrum of MED
and MED-like disorders associated with matrilin-3 mutations.
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ABSTRACT
Bilateral hereditary micro-epiphyseal dysplasia (BHMED) is a rare skeletal
disorder, first described by Elsbach (1959). We studied the extended BHMED
family again in order to determine whether this family indeed represents a separate
entity to be differentiated from other skeletal dysplasias, especially the multiple
epiphyseal dysplasias (MEDs).
The metacarpophalangeal pattern (MCPP) profile analysis is a well-recognized
valuable tool to detect changes in the length of hand bones on plain X-ray films in
various birth defects, skeletal dysplasias and other hand deformities. In this paper
we present the results of our measurements, showing statistically significant
differences in Q-scores of BHMED-affected individuals compared with MED-
affected individuals and controls. The MCPP profile analysis plots of the
measurements showed a curve, characteristic for BHMED, compared with
unaffected relatives and patients with EDM2.
We suggest that MCPP profile analysis will be applied more systematically in
the clinical and genetic analysis of MED.
In a previous study, we demonstrated that the disorder in this family can be
regarded as a clinically distict variant of MED due to a matrilin-3 mutation. In
view of subtle hand abnormalities we investigate the value of MCPP profile
analysis in clinical diagnosis of affected and unaffected family members using the
molecular diagnosis as gold standard, and compared our findings with MCPP
profile analyses from a family with EDM2 (n=10).
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INTRODUCTION
Bilateral hereditary micro-epiphyseal dysplasia (BHMED) is a rare skeletal
dysplasia with an autosomal dominant mode of inheritance with high penetrance,
reported by Elsbach in a Dutch family [1].
We re-examined the extended family according to a standard protocol. In view
of subtle hand abnormalities seen in BHMED, we quantified the abnormalities by
performing MCPP profile analyses.
During the first half of the last century, different methods of radiographic
measurements of the hand skeleton were developed [2,3]. In the 1970s, the first
statistical data on length of the hand bones for children of all ages and adults
became available from White American [4], Hungarian [5], and Venezuelan
populations [6]. The normal values for Japanese [7] and Nigerian population [8]
followed.
The metacarpophalangeal pattern (MCPP) profile analysis was developed by
Poznanski et al. [9]. The MCPP profile analyses is based on measurements of the
length of each of the 19 tubular bones of the hand on a postero-anterior (PA) X-ray,
and comparing these lengths with the standard of the normal population according
to age and sex. The results of this analysis can be visualised in the form of a graph,
a so-called ‘MCPP-plot’ representing relationships between the lengths of
metacarpal bones and phalanges compared to a reference population.
Normally, the MCPP profile remains more or less the same for one individual
throughout life. In most normal as well as bilaterally affected individuals there is
only minimal asymmetry between the left and the right hand, which makes it
sufficient to use one hand for the measurements [10]. Familial similarities can be
observed in normal families as well as in those with an inherited malformation.
MCPP profile analysis has proved to be a valuable method to detect absolute as
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well as proportional alterations in the length of the hand bones in various birth
defects. For several congenital malformation syndromes the pattern profile appears
to be specific [10].
The purpose of this paper is to report on the results of a study evaluating the use
of MCPP profile analysis in the delineation and recognition of BHMED-specific
hand abnormalities, compared with unaffected family members and patients from a
family with EDM2.
 Previously we demonstrated that the disorder in the family designated BHMED
by Elsbach (1959) is a clinically and radiologically distinct variant of MED due to
a matrilin-3 mutation (Mostert et al., 2003). Since we observed subtle
abnormalities of the hand, we investigated the value of MCPP profile analysis in
the clinical diagnosis of this MED variant while using the matrilin-3 mutation
analysis as a golden standard.
MATERIALS AND METHODS
Patients
All affected and unaffected living BHMED family members were examined in a
standard way including medical history, physical examination and radiology.
Additional laboratory examination was performed in some cases and samples were
taken for genetic analysis.
Concerning the hands, we made standardised X-rays of both hands of ten
clinically and radiologically BHMED-affected relatives and of three clinically and
radiologically unaffected individuals. We included only family members above the
age of 16 in order to reduce age-related variation [12]. The focus-film distance was
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1.15 m. and the hands were directly placed on the cassette, thus the magnification
in all subjects was the same. All physes were closed.
In addition, ten affected MED patients of an EDM2 family were radiologically
evaluated in the same way. As controls, we used the measurements of 45 healthy
Dutch persons without any known skeletal abnormality. With these radiographs we
performed metacarpophalangeal pattern (MCPP) profile plotting. The method
consists of measuring the length of the 19 tubular bones of the hand and comparing
this length with a standard of the normal population as the reference. The
standardised bone lengths in Z-scores will be calculated using the Poznanski data
for age and sex stratified bone lengths of White Americans [9]: 
Zi =  (bone lengthi – reference lengthi ) / SDi    ( i = the bone number).
The zero-line indicates the mean of the normal population (or reference line). The
Z-scores will be plotted against the individual bone number 1 to 19 representing
the first metacarpal (MC1) to the distal phalanx (DPh5).
The spread of the tabulated values of the reference standard deviations was a
disadvantage. Furthermore, references were only available in relatively large
intervals. It is also clear that the radiographs published in medical articles are of a
different size than normal life-size radiographs. These were reasons for introducing
the Q-score [13,14]. The Q-score is the 10logarithm of the quotient of the length of
the hand bone from a patient and the reference length for that bone. 
Q = 10log (bone lengthi / reference lengthi )   ( i = the bone number).
The reference length is calculated by a formula to adjust the reference to the exact
age of the patient. The length of the patient bones in the Q-score can be represented
as a percentage of the Reference length = 100 x (bone length / reference length) – 100,
adjusted to age and gender. Now also published X-rays can be measured, as the Q-
plot is a relative measurement tool.
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In the Q-plot, the numbers on the X-axis represent also the hand bones listed
from the first metacarpal (MC1) to distal phalanx (DPh5). The representation of the
Y-axis numbers is in percentages, that is the length of the metacarpals and
phalanges is calculated as the difference of the length of these bones from the
normal population (the reference length), as calculated by the Q-score.
It is noted that above the age of 20 the Z- and the Q-score do not differ
significantly from each other [12]. We present both scores since Q-scores are more
appropriate for statistical analysis and Z-scores for comparison with published
values.
STATISTICAL ANALYSIS
For an overall comparison of MCPP patterns of the different patients groups,
Pearson correlation coefficients were calculated. Significance testing on
differences between the patient groups (in order of MCPP bone lengths) was
performed using non-parametric one analysis of variance using the Kruskal-Wallis
test. In addition, two sample comparisons were made using two sample t-tests or
Wilcoxon rank-sum tests (two-sided tests), depending on the distribution of the
variables in the comparison, to try to identify where differences between groups
were. 
A p-value <0.05 was considered significant. However, since in the additional
comparisons of the individual MCPP bones no multiple comparison correction was
incorporated, the p-values of these tests should be interpreted descriptively.
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RESULTS
In BHMED affected family members, X-rays of the wrist showed an ‘ulna
plus’ with slight radial drift of the carpus and flattening of the ulnar part of the
radial epiphysis. X-rays of the hands demonstrated indeed short metacarpals, but
also a shortening of the proximal and midphalanges. The distal phalanges seemed
to have relative normal lengths. There were no deformities (Figure 1). 
The Z- and Q-plots were composed of the data, gathered by the measurements
of the 19 individual hand bones. The mean length of one bone in one group is
figured out in the plots. The unaffected BHMED persons did not have different
values compared to the randomly selected Dutch controls in the general population,
Figure 1.  PA-view of both hands of a 52-year-old affected male.
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matched for age and gender [15]. The Z-plots (Figure 2) and Q-plots (Figure 3) of
the affected family members show nearly the same profile. Both plots show a
remarkable and consistent profile in the BHMED affected family members. It is
not the exact height of the curve, which is most important, but the profile that
results from the individual lengthening or shortening of the bones [14].
Hand bone lengths of BHMED patients, MED (EDM2) patients and healthy
controls were compared using the Wilcoxon rank-sum tests. The clinical
observation of a relatively short metacarpal (MC) of the fourth and fifth digit when
clenching the fists in the BHMED patients is also illustrated in the Z- and Q- plots,
as MC2 and MC3 are less shorter than MC4 and MC5 compared to the normal
population or MED (Figures 2 and 3).
Figure 2 (Z-score). Mean Z-scores of the ten BHMED affected members of the family
(●–●–●), the three unaffected family members (□–□–□) and the ten MED (EDM2) affected
family members (○--○--○). The numbers on the X-axis represent the hand bones. They are
listed as Metacarpal bones 1 to 5 (MC1 to MC5), Proximal phalanges 1 to 5 (PPh1 to
PPh5), Middle phalanges 2 to 5 (MPh2 to MPh5) and Distal Phalanges 1 to 5 (DPh1 to
DPh5). The numbers on the Y-axis represent the Z-scores for each particular bone. The
zero line represents the mean of the healthy population (controls).
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In both the affected and the unaffected BHMED family members, the length of
MPh2 is shorter than MPh3, MPh4 and MPh5 (Figures 2 and 3).
The outcomes should be interpreted descriptively, because only pre-planned
comparisons should be used for conclusions concerning significant differences.
Significant differences were observed between the BHMED-affected family
members and the Dutch controls and between the affected-MED (EDM2) persons.
All reported p-values were two-sided (Table I).
Figure 3 (Q-score). Mean Q-scores of the ten BHMED affected members of the family
(●–●–●), the three unaffected family members (□–□–□) and the ten MED (EDM2)
affected family members (○--○--○). The numbers on the X-axis represent the hand
bones. They are listed as Metacarpal bones 1 to 5 (MC1 to MC5), Proximal phalanges 1
to 5 (PPh1 to PPh5), Middle phalanges 2 to 5 (MPh2 to MPh5) and Distal Phalanges 1
to 5 (DPh1 to DPh5). The numbers on the Y-axis (logarithm-scale) represent the Q-
scores in percentages for each particular bone. The zero line represents the mean of the
healthy population (controls).
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Table I. The results of the measurements of the 19 handbones between the BHMED-
affected family members, MED-affected (EDM2) family members and the Dutch controls
(Kruskal-Wallis test).
Affected
BHMED
Affected 
MED
Normal
population
Total p-value
MC_1 value Mean (±sem) -8.64 (±1.45) -6.03 (±1.75) -1.39 (±0.96) -3.22 (±0.82) 0.002
Median -8.00 -5.75 -2.10 -3.20
Q1–Q3 -12.10 – -5.60 -10.90 – -2.80 -5.90  –   2.90 -8.00 –  0.80
Min - max -16.80 – -1.80 -15.30 –  3.40 -12.90 – 14.70 -16.80 –14.70
N   10 10 45 65
MC_2 value Mean (±sem) -6.32 (±1.49) -9.10 (±1.95) -1.85 (±1.07) -3.65 (±0.90)     0.006
Median -6.50 -9.85 -0.80 -4.00
Q1 – Q3 -11.00 – -1.60 -11.80 – -8.30   -7.20 – 2.70 -9.00 – 1.60
Min - max -12.50 –  0.90 -17.10 –  3.80 -18.40 – 13.40 -18.40 –13.40
N   10 10 45 65
MC_3 value Mean (±sem) -6.68 (±1.53) -10.04 (±2.18) -1.50 (±1.08) -3.61 (±0.94) 0.001
Median -6.85 -10.90 -2.50 -4.10
Q1– Q3 -9.50– -5.10 -16.00 – -5.00 -4.90 – 3.60 -7.40 – 1.40
Min - max -15.20 – 2.00 -17.20 –  4.90 -18.00 – 15.60 -18.00 –15.60
N   10 10 45 65
MC_4 value Mean (±sem) -8.39 (±1.56) -10.31 (±2.34) -1.73 (±1.11) -4.08 (±0.98) <0.001
Median -9.65 -11.90 -1.90 -3.00
Q1– Q3 -11.00 –   -3.20 -16.40 –   -4.70 -5.40  –   2.60 -10.90 – 1.10
Min - max -16.70 –   -2.10 -17.60 –   4.40 -18.40 –  14.00 -18.40 –14.00
N   
MC_5 value Mean (±sem) -9.36 (±1.37) -10.77 (±2.31) -1.91 (±1.20) -4.42 (±1.03)    <0.001
Median -10.20 -10.95           -1.80    -3.60
Q1– Q3 -12.60 –   -8.20 -14.90 –   -7.80 -4.60  –   3.00 -9.20  –  0.20
Min - max -14.10 –   0.20 -22.50 –   5.30 -34.00 –  14.50 -34.00 – 14.50
N   10 10 45 65
PPh_1 value Mean (±sem) -8.29 (±2.42) -10.72 (±3.56) -2.57 (±1.09) -4.70 (±1.07) 0.007
Median -9.55 -12.70 -1.70 -3.90
Q1– Q3 -13.50 –   -5.70 -15.30 –   -2.90 -8.00  –   1.50 -10.90 –  0.60
Min - max -18.70 –   5.40 -32.00 –  10.30 -15.80 –  17.40 -32.00–  17.40
N   10 10 45 65
PPh_2 value Mean (±sem) -8.56 (±1.65) -6.61 (±2.65) -1.54 (±1.11) -3.40 (±0.96) 0.002
Median -10.75           -8.40 -1.60            -3.50
Q1– Q3 -12.00 –   -7.10 -12.30 –   -4.40 -5.60  –   1.90 -8.60  –  0.60
Min - max -13.30 –   3.40 -13.50 –  14.50 -17.20 –  18.00 -17.20 – 18.00
N   10 10 45 65
PPh_3 value Mean (±sem) -7.32 (±1.31) -9.10 (±2.28) -1.27 (±1.10) -3.41 (±0.95) <0.001
Median -8.60 -10.70 0.30 -4.20
Q1– Q3 -10.70 –   -4.60 -13.40 –   -6.20 -5.30  –   2.10 -8.70  –  1.40
Min - max -11.30 –   1.50 -17.70 –   8.40 -18.00 –  18.30 -18.00 – 18.30
N   10 10 45 65
PPh_4 value Mean (±sem) -7.72 (±1.60) -7.26 (±2.66) -1.15 (±1.07) -3.10 (±0.94) 0.004
Median -9.95 -10.75 -0.60 -3.00
Q1 – Q3 -11.60 –   -4.20 -12.10 –   -2.00 -5.00  –   3.30 -9.90  –  1.90
Min - max -11.70 –   2.50 -17.30 –  11.60 -17.70 –  16.90 -17.70 – 16.90
N   10 10 45 65
PPh_5 value Mean (±sem) -6.01 (±1.83) -6.09 (±2.47) -2.28 (±1.04) -3.44 (±0.88) 0.066
Median -8.00 -9.00 -2.00 -3.00
Q1 – Q3 -11.10 – -0.70 -10.50 –   -3.80 -7.00  –   1.10 -9.70  –  1.10
Min - max -11.70 –  3.90 -13.90 –  12.20 -17.50 –  13.30 -17.50 –13.30
Continued
 on p. 124
N   10 10 45 65
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Table I continued.
Affected
BHMED
Affected 
MED
Normal
population
Total p-value
MPh_2 value Mean (±sem) -9.08 (±1.86) -11.33 (±1.79) -4.40 (±1.22) -6.19 (±0.99) 0.018
Median -9.90 -12.35 -3.20 -6.30
Q1 –Q3 -13.90 –  -2.80 -15.70 –  -8.80 -9.70  –   1.40 -12.30 – -1.10
Min - max -17.40 –   0.10 -17.80 –   2.10 -21.50 –  13.30 -21.50 –13.30
N   10 10 45 65
MPh_3 value Mean (±sem)  -6.90 (±1.70) -10.74 (±2.08) -2.68 (±1.24) -4.57 (±1.02) 0.010
Median -7.35 -10.95 -1.50 -4.80
Q1 – Q3 -9.90  –   -3.70 -15.30 –  -8.10 -8.60  –   3.00 -10.40 – 1.30
Min - max -14.40 –   3.10 -19.00 –   3.30 -20.10 –  12.70 -20.10 –12.70
N   10 10 45 65
MPh_4 value Mean (±sem) -7.07 (±2.00) -9.72 (±2.28) -2.18 (±1.12) -4.09 (±0.97) 0.007
Median -7.80 -10.70 -1.50 -5.30
Q1– Q3 -11.00 –  -5.30 -15.00 –  -6.00 -7.30  –   2.90 -9.10 – 2.30
Min - max -15.70 –  4.90 -19.70 –   5.00 -20.90 –  13.20 -20.90– 13.20
N   10 10 45 65
MPh_5 value Mean (±sem) -8.58 (±2.26) -13.29 (±4.22) -3.83 (±1.30) -6.01 (±1.22) 0.013
Median -8.75 -15.20 -3.20 -4.90
Q1– Q3 -14.10 –  -2.80 -17.40 –  -3.20 -8.60  –   3.20 -14.00 –   2.10
Min - max -18.40 –   2.00 -41.40 –   7.60 -24.70 –  12.90 -41.40 –  12.90
N   10 10 45 65
DPh_1 value Mean (±sem) -7.67 (±2.05) -15.44 (±2.27) -5.00 (±1.57) -7.02 (±1.26) 0.002
Median -7.85 -16.30 -4.30 -6.90
Q1 - Q3 -13.60 – -2.70 -20.70 – 12.70 -9.00 – 2.50 -12.70 –   0.20
Min - max -16.40 –   3.30 -26.50 –   -1.20 -40.50 –  12.20 -40.50 –  12.20
N   10 10 45 65
DPh_2 value Mean (±sem) -3.33 (±2.20) -12.11 (±2.48) 0.36 (±1.25) -2.12 (±1.13) <0.001
Median -1.70 -12.05 -1.00 -1.30
Q1– Q3 -5.90  –   1.30 -17.00 –   -5.60 -2.10  –   4.80 -7.50  –   3.00
Min - max -15.30 –   6.80 -27.20 –   -0.70 -20.50 –  17.20 -27.20 –  17.20
N   10 10 45 65
DPh_3 value Mean (±sem) -5.59 (±1.35) -10.80 (±2.28) -1.07 (±1.22) -3.26 (±1.03) 0.001
Median -5.10 -10.95 -2.10 -3.70
Q1 – Q3 -7.10  –   -3.70 -15.20 –   -4.10 -5.90  –   2.70 -8.70  –   2.00
Min - max -12.20 –   2.00 -21.30 –   1.20 -19.20 –  17.30 -21.30 –  17.30
N   10 10 45 65
DPh_4 value Mean (±sem) -5.57 (±2.10) -9.93 (±2.60) -2.06 (±1.18) -3.81 (±1.02) 0.015
Median -3.70 -9.85 -2.40 -4.00
Q1 – Q3 -10.40 –   -1.00 -16.90 – -7.10 -6.10  –   3.10 -8.60  –   1.30
Min - max -20.30 –   2.60 -19.80 –   7.30 -18.80 –  13.60 -20.30 –  13.60
N   10 10 45 65
DPh_5 value Mean (±sem) -5.00 (±2.94) -9.41 (±3.44) -1.16 (±1.20) -3.02 (±1.13) 0.024
Median -0.65 -10.85 -1.40 -1.80
Q1 – Q3 -10.20 –   0.90 -14.60 –   -1.30 -6.30  –   4.10 -8.20  –   3.10
Min - max -24.60 –   5.70 -29.40 –   9.90 -18.80 –  12.50 -29.40 –  12.50
N   10 10 45 65
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DISCUSSION
In BHMED, bilateral simultaneous onset of pain in hip and knee joints, short
stature, waddling gait and restricted range of motion of the hip were seen in the
affected family members. The hands appeared to be relatively broad and short.
However, when clenching the fists, a shortening of the metacarpals (MC),
especially MC IV and V was noticed. In our measurements, the Z- and Q-plots
confirmed this observation. The plots show a characteristic and consistent profile.
The disproportionally shortened MPh2 in affected as well as unaffected BHMED
family members strongly suggests that this is a family trait that is independent of
the BHMED trait. We also have to take into account that unaffected BHMED
family members have a smaller height compared to the normal (Dutch) population,
which can be explained by the fact that BHMED patients seem to marry
preferentially with persons of smaller height, who make a genetic contribution to
the next generation independent of the segregation of the gene for BHMED [16].
MCPP pattern plotting seems limited to the analysis of discriminating affected
and unaffected persons within one family. It is not the exact height of the curve,
which is most important, but the profile that results from the individual lengthening
or shortening of the bones. Characteristic profiles for BHMED are represented in
figures 2 and 3.
Discrimination between different dysplasias with the MCPP profiles is possible,
but only when the profiles are quite different. Especially in the multiple epiphyseal
dysplasia (MED), where short, stubby fingers are seen, the radiological features are
different from BHMED. MED shows a more generalised shortening of all bones of
the hand, whereas in BHMED the bones of the hand other than MC IV and V are
less shortened than in MED, which is in agreement with the clinical observation of
disproportionally shortened MC IV and V.
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The finding of a pathogenic mutation in MATN-3 in this family (A128P), which
completely segregated with the clinical affection status [11], demonstrated that
BHMED belongs a variant of MED (i.c. EDM5).
We conclude that MCPP profile analysis comfirmed subtle hand abnormalities
in BHMED and suggest that MCPP profile analysis will be more systematically
applied in the clinical and genetic analysis of MED and its genetic variants.
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In this study, we attempted to address the following questions:
1. Is BHMED indeed a separate clinical entity among the MEDs?
2. What are the diagnostic radiographic features of BHMED?
3. What is the molecular genetic basis of BHMED?
4. What is the diagnostic value of metacarpophalangeal pattern (MCPP) profile
analysis?
Is BHMED indeed a separate clinical entity among the MEDs?
The phenotypical description of Elsbach findings on a Dutch family (1959),
40 years ago, suggested a familial trait, in which an autosomal dominant dys-plasia
was the inheritance pattern. He stated that his findings were different from the
known MED, especially the radiological findings of small epiphyses of the hip.
We re-examined the extended family and all subjects over 4 years old were
included (no subjects below this age were available). Our observations confirm that
the disorder in this family belongs to the MED group, but can be distinguished
from other MEDs in this group. Special features are early-onset bilateral onset of
complaints (pain in hip and knees), and small epiphyses, i.e. ‘micro-epiphyses’.
MCPP profile analysis of affected family members further underlined the distinct
pattern of skeletal features in this disorder by showing a specific pattern different
from the most common form of MED, EDM1.
Thorough clinical and radiological examination of the affected and unaffected
family members was needed in order to obtain a reliable clinical phenotype
definition and to sort out branches of the family that did not have the disease. In all
affected cases, the radiological findings confirmed the clinical findings. It was
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important to differentiate specific dysplasia complicated by osteoarthritis from
aspecific osteoarthritis without a predisposing dysplasia. The application of a
standardized protocol for medical history, physical examination and radiological
evaluation was essential in obtaining these results. 
A small height may lead towards selection of a partner who also has a smaller
height. Therefore we examined also the spouses of affected family members who
had offspring, and paid equally well attention to the possibility that a smaller height
among spouses may be associated with an increased risk of another skeletal
dysplasia gene being married in into the family. We did not find evidence for a
second skeletal dysplasia but observed indeed that on average spouses of affected
family members were shorter than controls. This may explain why unaffected
children of patients in this family also had a shorter height. It suggests that the
short stature in BHMED patients as compared to the general population is due to
the combined effect of the dominant gene mutation and the polygenetic
background of both parents and a possible role of non-random partner selection in
quantitative traits like height.
Indeed, the literature confirms the role of height-related partner selection
(Hensley, 1994; Roscoe et al., 1987). It is evident that total body height (TBH) is
not a distinctive inclusion criterion when defining the affection status in a skeletal
dysplasia with mild to moderate effect on final adult height and with no or only
limited reduction of reproductive fitness.
What are the diagnostic radiographic features of BHMED?
Although clinical symptoms strongly suggested that the ‘Elsbach family’ has a
distinct form of MED, radiological findings provided more conclusive evidence for
BHMED as a separate entity. In BHMED, the well-developed ossification centre of
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the epiphyses is small and homogeneous, whereas in MED accessory ossification
centres are seen, scattered in the periphery of the cartilaginous epiphyses. With
regard to the weight-bearing joints, especially the hip joints, the flattening of the
femoral head is due to mechanical stress, probably resulting in secondary degen-
erative osteoarthritis in later life (see Appendix 1). The ulcera and osteochondritis
dissecans-like defects may possibly have the same origin. In BHMED, the
metacarpals and phalanges are short, but the distal phalanges not stubby as in MED
(Mourik van, 1998). The ‘V’ wrist joint deformity in MED which is due to
hypoplasia of the adjacent portions of the radial and ulnar epiphyses, was not
observed in BHMED, although affected subjects showed deformity of the ulnar
part of the distal radial epiphysis. In BHMED, the carpal bones are of normal size
without irregularities, whereas they are small and irregular in MED.
In the ‘Elsbach family’, the spine is not affected. In MED, the spine shows
minimal flattening and reduction of the vertebral bodies. In the ‘Elsbach family’
the femoral head was medially flattened in every affected relative, whereas in
MED a large variation of abnormalities may be observed ranging from normal to
gross deformation.
We used our own developed X/Y ratio scoring system because of the marked
reduced height of the intercondylar notch in BHMED-affected patients. The
measurements stated by Schlesinger (1986) compare only the width of the distal
femoral metaphysis and that of the accompanying epiphysis. The notch height is
not measured.
In summary, BHMED shows a unique pattern of radiographic abnormalities that
are distinct from common MED. Radiographic examination was an important tool
in delineating the phenotype in this family, and may be of great value in
differential phenotyping of new MED families that are not yet genetically or
molecularly characterized. 
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What is the molecular genetic basis of BHMED?
After clinical and radiographical phenotyping, linkage analysis in the ‘Elsbach
family’ showed no linkage to previously known loci for autosomal dominant MED,
EDM1-3, and revealed linkage to a region harbouring the matrilin-3 gene.
Subsequently, a missense mutation was found within the von Willebrand domain of
this gene, which was not observed among healthy population controls. Shortly
before our discovery, this gene was found to be mutated in the two families
reported by Chapman et al. (2001). Although the clinical description of these two
reported families is rather scarce, the available information suggests that the
phenotypes resemble that of our family and are distinct from common MED. In
view of the role of matrilin-3 in the build-up of the extra-cellular matrix as
reviewed before, and of what is currently known about the temporospatial expres-
sion patterns of matrilin-3, defects of matrilin-3 can indeed be held responsible for
the clinical phenotype of BHMED. Detection of other mutations in the different
domains of matrilin-3 and analysis of the associated clinical pictures will help to
obtain more insight into the role of matrilin-3 in connective tissue assembly and its
interplay with other molecules.
What is the diagnostic value of metacarpophalangeal pattern (MCPP) profile
analysis?
Many congenital or hereditary disorders are characterized by a subtle pattern of
skeletal abnormalities of the hand. This may reflect into small but specific changes
of the absolute and relative length of hand bones. The MCPP profile analysis is a
useful instrument in making these abnormalities visible as an abnormal pattern and
available for interpretation. MCPP profile analysis can be used twofold: to increase
the (differential) diagnostic precision and to analyze the segregation pattern within
the family. Sometimes it may also be helpful in sorting out features that are related
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to the genetic condition or that are representing variants running in the family as a
kind of skeletal polymorphism. All of these aspects played a role in this study. We
observed a MCPP plot that showed a clear difference from that of EDM2. MCPP
profile analysis of available family members gave results that were consistent with
the segregation of BHMED according to preset clinical and radiological criteria.
This was confirmed by the results of linkage and mutation analysis. In addition,
MCPP profile analysis demonstrated that a disproportionately short second digit in
this family was due to a short MPh2 not related to BHMED but a feature that
independently run through the family and represented a constituent of the genetic
family background.
PROSPECTS FOR FUTURE RESEARCH
The identification of gene defects causing a skeletal dysplasia may help patients
and families to understand the nature of the disease, comprehend the genetic risks
to the offspring, and obtain adequate genetic counselling. This study illustrates the
importance of clinical and molecular genetic analysis to the family. One whole
branch of the family that was thought to be affected was found to be clinically
unaffected. The occurrence of slightly short stature in combination with aspecific
osteoarthropathy and heteroanamnestic ‘hear say’ information may have mislead
Elsbach in his original study. In addition, one young family member that was
thought to be affected clinically was found not to be affected on the basis of
radiographic examination and absence of the matrilin-3 mutation confirmed she
had not inherited the disease. 
DISCUSSION
___________________________________________________________________
136
As mentioned in the introduction, MED is regarded as a rather rare disorder,
even when taken as a group. Its prevalence is estimated as 11.2 per 1 million based
on index patients, and 16.3 per million, if affected relatives are included (Wynne-
Davies and Gormley, 1985). Later estemates showed a prevalence of 9:100,000
(Taybi and Lachman, 1996). Based on these highly different estimates the total
number of persons with MED in the Netherlands may vary between 168–244 and
3600. Thus, every Dutch hospital cares for at least 1–2 to 15 patients with MED.
However, hidden behind the non-specific label of ‘bilateral premature
osteoarthritis’, MED may be more common than appreciated. There are a number
of ‘normal’ individuals who, in addition to premature degenerative changes of
weight-bearing joints, show involvement of two or more joints and have a history
of similar disease in near relatives. This suggests that there are many more patients
with milder or less typical forms of disease that share a common molecular
mechanism. The extension of our knowledge may go into two directions. First, the
currently known loci for autosomal dominant MED represent probably the tip of an
iceberg. Second, we have to take into account the possibility that the currently
known genes may show slight variations of the coding sequences or the promoter
elements that may give rise to modulating effects in more common
osteoarthropathies with complex aetiology. This requires larger scale genetic
epidemiological studies. Conversely, ‘larger’ mutations of these genes may induce
more severe abnormalities giving rise to clinical phenotypes that are lethal or not
consistent with reproduction, and therefore may be associated with sporadic
occurrence rather than familial presentation with an autosomal dominant mode of
transmission. Clinical analysis of patients with chromosomal microdeletions or
partial triploidies of the regions encompassing the MED associated genes may be
helpful to explore the effect of haploinsufficiency (through microdeletion) or triple
gene dose effect (through partial trisomy). In sporadic patients, precise clinical
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phenotyping in combination with large scale testing of functional candidate genes
may be needed in order to estimate the role of new mutations in severe cases. 
Knowledge of the genes involved in monogenic MED and multifactorial
osteoarthropathies will foster our understanding of the molecular basis of these
disorders, its environmental risk factors, its prognosis, and ultimately the
individualized risk-benefit assessment of different treatments. Comprehension of
the molecular mechanism may also lead towards innovative molecular treatment
modalities, for example through the design of replacement materials that provide a
surface for specific interaction with surrounding human tissues and better
integration in the human body.
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This thesis is based upon a study of a Dutch family with a unique skeletal
dysplasia first described by Elsbach in 1959. Clinical features were early onset of
bilateral symmetric synchronic complaints of pain in hip and knee, and
radiographically small epiphyses of the hip joint. Although Elsbach regarded this
disorder as different from common multiple epiphyseal dysplasia, McKusick
suggested that it was not different from what was defined later as Fairbanks and
Ribbing types of MED. Since the latter disorders were proven to be caused by
mutations in the COMP gene, this assumption became amenable to verification or
falsification. Furthermore, the family requested genetic counselling and wanted be
informed about the genetic risks to the offspring and to obtain more information
about the nature of the disease. 
The aim of the study (Chapter 2) was to obtain answers to four main questions:
1. Is BHMED indeed a separate clinical entity among the MEDs?
2. What are the diagnostic radiographic features of BHMED?
3. What is the molecular genetic basis of BHMED?
4. What is the diagnostic value of metacarpophalangeal pattern (MCPP) profile
analysis?
A review of the literature on MED and MED-relate disorders is given with
respect to clinical symptoms (Chapter 3.1), genetics (Chapter 3.2), pathogenesis
(Chapter 3.3) and course and treatment (Chapter 3.4). 
In Chapter 4.1, the results of the clinical study of the ‘Elsbach family’ are given.
The study included the original family including 40 years follow-up period, as well
as new family members born since the first report by Elsbach. By application of a
standard protocol for clinical and radiological evaluation and personal examination
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of all family members, the phenotype in the family was defined more precisely.
The findings confirmed Elsbach’s conclusion that the disease in this family,
designated by him as BHMED, indeed represents a separate entity that can be
differentiated from common MED. However, the study also revealed that in one
branch of the family the diagnosis of BHMED by Elsbach was incorrect. 
Short stature was not only observed in affected patients, but also though to a
lesser degree in their healthy siblings and the unaffected parents. This observation
made it clear that short stature by it self is not a good clinical criterion for the
diagnosis of autosomal dominant skeletal dysplasias with mild shortening of stature
and preserved reproductive fitness. Through height-related partner choice, affected
as well as unaffected offspring will on average share the same genetic background
which is enriched for genetic factors for being short. This also indicated that the
effect of the mutation for BHMED on height is probably less than observed by
comparing the height of patients with population controls. One has to be aware that
this influx of genes for being short probably may have been going on for a number
of successive generations. 
The radiographic findings were described and analysed in more detail in
Chapter 4.2. BHMED could again be distinguished from common MED by a
specific combination of features mainly consisting of hip abnormalities
characterized by a valgus angle of the femoral neck which is short and thickened,
flattening of the head of the femur and the femoral epiphysis especially at the
medial part -at the site of the fovea centralis-, and dysplasia of the acetabulum as
expressed by a lack of development of the normal teardrop configuration of the
medial acetabular wall. The abnormalities of the knee were characterised by
dysplastic deformities like flattened and small condyles, especially on the lateral
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view in contrast with unaffected family members. In a few cases there was a focus
of osteochondritis dissecans and in others an ulcus was seen at the lateral femoral
condyle. All affected family members showed a shallow intercondylar notch on the
AP view of the knee compared to the unaffected family members. Besides, a
number of other or less specific skeletal abnormalities were found. In one family
member the clinical diagnosis of BHMED was not confirmed radiographically. 
Through linkage analysis three candidate loci, EDM1-3 cold be excluded
(Chapter 4.3). A whole genome scan was started which revealed linkage to a region
on chromosome 2 harbouring a functional candidate gene, matrilin-3. At this phase,
a report by Chapman et al. appeared suggesting that mutations of matrilin-3 indeed
were associated with variant forms of MED. The clinical phenotype of these
families is not well described but shows certainly a number of similarities with
those of the Elsbach family. Mutation analysis of matrilin-3 revealed a previously
unreported missense mutation in the von Willebrand domain of this gene (G382C
base pair substitution leading to an A128P amino acid substitution). This change
concerns an evolutionary highly conserved amino acid. In addition, the mutation
was not found in 187 healthy controls. Taken together, it was concluded that this
mutation is indeed the genetic cause of BHMED. These findings confirm Elsbach’s
and our observation that the phenotype in this family is indeed distinct from
common MED or Fairbanks and Ribbing type of MED (EDM1), contrary to
McKusick’s assumption (OMIM, 2002). 
The mutation segregated completely with the preset affection status which
required fulfilment of the criteria for both clinical and radiographic diagnosis. The
mutation was absent in the branch of the family that we diagnosed as unaffected
contrary to Elsbach’s original description. The mutation was also absent in the
patient who showed clinical signs of BHMED but which could not be confirmed
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radiographically. This shows the usefulness of supplementary radiological
examination for the clinical diagnosis in individual patients and for phenotyping in
preparation for molecular genetic analysis. 
The MCPP profile observed in BHMED was found to be different from that of
EDM2 and was consistent with the clinical diagnosis, the radiological observations
and the segregation of the matrilin-3 mutation (Chapter 4.4). By MCPP profile
analysis we were also able to determine that a disproportionally shortened MPh2 in
affected as well as unaffected BHMED family members was a family trait that is
independent of the BHMED trait. This study demonstrated the great power of
MCPP profile analysis for phenotypic classification in studies of large family with
multiple affected persons. Its differential diagnostic value in individual patients,
seen independent from a family or family history, was not a specific subject of this
study.
Chapter 5 provides a comprehensive discussion of the results of this thesis and a
number of reflections on prospects for the future. The four aims of the study,
further clinical delineation of the BHMED phenotype, radiographic
characterisation, identification of its molecular genetic basis, and establishing the
complimentary value of MCPP profile analysis using the genotype as golden
standard were all accomplished. 
The study also revealed an interesting role for height-related partner choice on
the polygenetic background against which the matrilin-3 gene affects height. Our
observations may stimulate the development of models to measure the independent
contributions and interactions of major and minor gene effects in quantitative traits
in general. 
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The identification of genes involved in skeletal dysplasia and predisposing to
premature osteoarthropathies may also help to gain more insight into the complex
developmental and molecular basis of these disorders, to develop new methods of
treatment, to select the best treatment in case similar clinical conditions due to
different underlying defects respond differently, to identify environmental risk
factors that may provide a grip for preventive action, and to provide a sound basis
for genetic counselling.
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Deze dissertatie is gebaseerd op een onderzoek naar een Nederlandse familie
met een unieke skelet dysplasie, die voor het eerst werd beschreven door Elsbach
in 1959. De klinische verschijnselen die hij beschreef traden op in de vroege
kinderjaren en bestonden uit dubbelzijdig en gelijktijdig optredende, symmetrische
klachten van pijn in met name heup en knie met daarbij radiologisch kleine
epiphysen van het heupgewricht. Hoewel Elsbach deze bevindingen beschouwde
als anders dan die van de bekende multipele epiphyseaire dysplasie (MED),
suggereerde McKusick reeds dat deze bevindingen waarschijnlijk niet anders
waren dan die later werden gedefinieerd als het Fairbanks en Ribbing type MED.
Zodra de laatst genoemde aandoening bleek te worden veroorzaakt door mutaties
in het cartilage oligo matrix protein (COMP)-gen, werd deze veronderstelling
hanteerbaar voor verificatie of falsificatie. Hierbij kwam dat de familie zelf vragen
had over de erfelijkheid en de aard van de aandoening en geïnformeerd wilde
worden over de genetische risiko’s voor het nageslacht. Bij velen van hen leefde
het verhaal dat een verre voorvader in Nederlands-Indië door een krokodil was
gebeten, en dat daardoor de aandoening in de familie gekomen was. 
Het doel van deze studie (Hoofdstuk 2) was antwoorden te verkrijgen op de
volgende vragen: 
1. Is bilaterale hereditaire micro-epiphysaire dysplasie (BHMED) inderdaad een
aparte klinische entiteit binnen de grotere groep van MEDs?
2. Wat zijn de diagnostische, radiologische kenmerken van BHMED?
3. Wat is de moleculair genetische basis van BHMED?
4. Wat is de diagnostische waarde van metacarpophalangeal pattern (MCPP)
profile analysis?
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Een literatuurstudie naar MED en MED-gerelateerde aandoeningen wordt
gegeven ten aanzien van de klinische symptomen (Hoofdstuk 3.1), de genetica
(Hoofdstuk 3.2), de pathogenese (Hoofdstuk 3.3) en beloop en behandeling
(Hoofdstuk 3.4). 
In Hoofdstuk 4.1 worden de resultaten beschreven van de klinische studie van
de ‘Elsbach familie’. Deze studie bevat de oorspronkelijke familie, inclusief 40 jaar
follow-up, als ook familieleden die na die eerste publicatie van Elsbach zijn
geboren. Door gebruik te maken van een gestandaardiseerd protocol voor klinische
en radiologische evaluatie en individueel onderzoek van alle familieleden kon het
phenotype van de familie nauwkeuriger worden gedefinieerd. De bevindingen
bevestigden Elsbach’s conclusie dat de aandoening in deze familie, door hem
benoemd als BHMED, inderdaad een aparte entiteit vormt die kon worden
gedifferentieerd van de bekende MED. Echter, uit ons onderzoek bleek dat hij ook
een tak van de familie abusievelijk met BHMED had aangemerkt.
Een korte lichaamslengte werd niet alleen gezien bij aangedane familieleden,
maar in mindere mate ook bij niet-aangedane familieleden en de gezonde partners.
Deze observatie maakt duidelijk, dat een korte lichaamslengte op zichzelf genomen
geen goed klinisch criterium is voor de diagnose van een autosomaal dominante
skelet dysplasie met een mild verkorte lichaamslengte en behouden reproductieve
‘fitness’. Door ‘height-related partner choice’ zullen zowel aangedane als ook niet-
aangedane familieleden gemiddeld dezelfde genetische achtergrond delen die is
verrijkt met genetische factoren voor de kortere lichaamslengte. Dit geeft tevens
aan, dat het effect van de mutatie voor BHMED voor wat de lichaamslengte betreft
waarschijnlijk minder is dan dat gezien wordt in vergelijkbare gezonde controles
en de gegevens van het CBS. Men dient er rekening mee te houden, dat deze influx
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van genen voor de kortere lichaamslengte over generaties heen een rol kan hebben
gespeeld. 
De radiologische bevindingen worden beschreven en specifieker geanalyseerd
in Hoofdstuk 4.2. BHMED kan wederom worden onderscheiden van de bekende
MED door een specifieke combinatie van kenmerken, die voornamelijk bestaan uit
heupafwijkingen, zoals coxa valga met een verkort en verdikt collum femoris, een
afplatting van de femurkop, met name aan de mediale zijde van de epiphyse -aan
de zijde van de fovea centralis-, en een dysplastisch acetabulum met een matige
ontwikkeling van de ‘teardrop configuration’ aan de mediale acetabulaire wand. De
afwijkingen van de knie worden gekarakteriseerd door dysplastische deformiteiten
zoals afgeplatte en kleine femurcondylen, met name op de laterale opname, in
vergelijking met de niet-aangedane familieleden. In een aantal gevallen werd er een
haard van een osteochondritis dissecans gevonden en bij weer anderen werd een
ulcus gezien in de laterale femurcondyl. Alle aangedane familieleden vertoonden
een vlakke intercondylaire notch op de voor-achterwaartse opname van de knie,
vergeleken met de niet aangedane familieleden. Daarnaast werd een aantal minder
specifieke skelet afwijkingen gevonden. In één familielid kon de klinische
diagnose BHMED radiologisch niet worden bevestigd. 
Door middel van linkage analyse konden drie kandidaat loci, EDM1-3 worden
uitgesloten (Hoofdstuk 4.3). Vervolgens werd een volledige genoom scan
uitgevoerd, die linkage toonde met een regio op chromosoom 2 die op zijn beurt
een functioneel kandidaatgen, matrilin-3 (MATN-3), bleek te bevatten. Juist op dat
moment verscheen een publicatie door Chapman et al. (2001), die suggereerde dat
mutaties van MATN-3 inderdaad geassocieerd waren met varianten van MED. Het
klinische phenotype van de door hen onderzochte families was relatief summier
CHAPTER 6
___________________________________________________________________
149
omschreven, maar vertoonde zeker een aantal overeenkomsten met die van de
‘Elsbach familie’. Mutatie analyse van matrilin-3 in onze familie toonde een
nieuwe missense mutatie aan in het von Willebrand domein van dit gen (G382C
basepaar substitutie, resulterend in een A128P aminozuur substitutie). Het betreft
een aminozuur dat evolutionair hoog geconserveerd is. Voorts werd deze mutatie
niet gevonden in 187 gezonde controle personen. Hieruit werd geconcludeerd dat
deze mutatie inderdaad de genetische oorzaak van BHMED is. Deze bevindingen
bevestigen Elsbach’s en onze waarneming dat het phenotype van de skeletdysplasie
in deze familie inderdaad anders is dan dat van de bekendere en vaker
voorkomende MED (Fairbanks en Ribbing type) (EDM1). Hiermee is tevens
McKusick’s (OMIM) aanname dat het om eendere aandoeningen zou gaan
weerlegd. 
De mutatie segregeerde volledig met de aandoening zoals voorafgaand op grond
van klinsche en radiologische kenmerken vastgesteld. De mutatie was niet
aanwezig in een tak van de familie waarin wij in tegenstelling met Elsbach’s
originele beschrijving de diagnose niet konden stellen. De mutatie werd ook niet
gezien in de patiënt, die weliswaar klinisch verschijnselen van BHMED vertoonde,
maar waarbij dat radiologisch niet kon worden bevestigd. Deze bevinding
onderschrijft nog eens de waarde van aanvullend radiologisch onderzoek voor de
klinische diagnose bij individuele patiënten en de phenotypering ter voorbereiding
op moleculair genetische analyse. 
Het MCPP-profiel, zoals wij dat vonden bij BHMED, was significant anders
dan dat van EDM2 en was consistent met de klinische diagnose, de radiologische
waarnemingen en de segregatie van de matrilin-3 mutatie (Hoofdstuk 4.4). Door de
MCPP profile analysis konden we aantonen, dat een gedisproportionaliseerd
verkorte middenphalanx van digitum 2 manus (MPh2) bij zowel aangedane als
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niet-aangedane BHMED familieleden aanwezig was, en welke derhalve los staat
van de aandoening BHMED. Deze studie toonde de grote waarde van de MCPP-
profiel analyse voor phenotypische classificatie bij onderzoek van grotere families
met veel aangedane personen. De differentiaal diagnostische waarde bij patiënten
die niet in samenhang met familieleden kunnen worden onderzocht, was geen
specifiek onderwerp van dit onderzoek. 
Hoofdstuk 5 bevat een uitgebreide discussie van de resultaten van deze
dissertatie en een aantal kanttekeningen ten aanzien van toekomstig
wetenschappelijk werk. De vier doelen van deze studie, verdere klinische
beschrijving van het BHMED-phenotype, radiologische karakterisering,
identificatie van de moleculair genetische basis, en het bevestigen van de
aanvullende waarde van de MCPP profile analysis met gebruik van het genotype
als gouden standaard, werden alle bereikt. Deze studie toonde ook de mogelijk
belangrijke rol van de door ‘height-related partner choice’ beïnvloede
polygenetische achtergrond tegenover de matrilin-3 gen effecten ten aanzien van
totale lichaamslengte. Onze waarnemingen kunnen wellicht een bijdrage leveren
aan het ontwikkelen van modellen waarmee de afzonderlijke bijdragen en
interacties van geneffecten op kwantitatieve kenmerken worden gemeten. 
De identificatie van genen die betrokken zijn bij skeletdysplasieën en
predisponeren voor premature osteoarthropathieën, kan ook bijdragen tot een beter
inzicht in de complexe ontwikkeling en moleculaire basis van deze aandoeningen,
voor het ontwikkelen van nieuwe behandelingsmethoden, tot de keuze van de beste
behandeling in geval van vergelijkbare klinische condities met toch verschillende
onderliggende defecten, tot het identificeren van exogene risicofactoren die een
aangrijpingspunt voor preventieve maatregelen kunnen opleveren, en tot het
verschaffen van een goede basis voor genetische counselling. 
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ENGLISH
B.R.H. Jansen, MD, PhD, dear co-promoter and supervisor, dear doctor
Jansen, after to-day perhaps: dear Bernard (?). Thanks to your inspiration and
supervision, this work could be undertaken and completed. In times of doubt, there
was yet another supportive telephone call, sometimes even in the early hours of the
night. Whenever progress tended to slow down, we put our heads together again. A
second baby was welcome only when the second article was finished. The third one
after the third article and so on. At the time, our interests ran parallel. Many thanks
for your encouragement with the multiplicity of sayings from a wide range of
backgrounds.
Professor D. Lindhout, esteemed promoter, dear Dick, it is with great pleasure
that I recall the many hours in your attic room at Leiden, which appeared to be so
productive but did not pass as quickly as I wished. I will not easily forget the
delicious (Danish) lunches served by your wife Lisbeth. Your accuracy has borne
fruit, although often at a pace too slow for surgical specialists. Dick, I am grateful
for your stimulating perseverance.
Professor J.R. van Horn, esteemed promoter, dear teacher, dear Jim. From the
beginning of the study you have been involved in designing it. You have always
stimulated me to finish the thesis during the training for an orthopaedic surgeon.
When this misfired, you even thought that the cigar may go out. But you see, just a
little puff and the tobacco starts to glow again. Jim, after an eventful period in the
field of health, I am glad that together we have finalised the work.
P.F. Dijkstra, MD, PhD, highly valued as a colleague but rather as a human
being. Unfortunately, you are unable to join in the completion of our scientific
work. This summer we received the tragic news. Initially, you were an essential
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link in the radiological confirmation of being affected with BHMED or not.
Without your help, our latest article would never have become what it is now. 
E. Wesby-van Swaay, MD, PhD, dear Eveline. When we had mapped the
BHMED family initially, we got into contact with clinical genetics in Rotterdam,
which led us to you. Your comments on the physical examination, which in
clinical-genetic terms is more comprehensive than its orthopaedic counterpart,
were very useful. We re-examined many relatives, finding abnormalities, including
those of the hands. We are still in touch, even though you are far away in Helsinki,
Finland. Fare you well.
P. Heutink, MD, PhD, dear Peter. In spite of your many current research lines
in clinical genetics, you have been of great value for the practical characterisation
of the BHMED genome. How pleased we were when your E-mail revealed that the
gene defect had been found. Peter, many thanks and I wish you good luck in your
future steps forward.
N.J.G.M. Veeger, dear Nic. During my academic year, we have racked our
brains for many an hour over the MCPP data. My special thanks are due to you for
your value as a statistician, who has taught me its principles.
Laurieke van Kammen, dear Laurieke, you were the central figure in the first
clinical phase at Delft, where I was given the opportunity to see the many relatives
in the evening and where you succeeded in tracing (their) X-rays from all over the
country in an excellent way. Many thanks to you.
Jolanda Hoekstra, “my” secretary. Jolanda, you did one thing my wife Cora is
not allowed to do at home: clearing my desk. When it – frequently – came to pass
that I had a mere 10 square centimeters to write on at my desk, you were the one to
multiply it by a factor 10. I am sorry you are going to leave us.
Linda Offermans, Professor Lindhout’s secretary at Utrecht, a special word for
you. Especially in the final phase of the completion of the doctoral thesis, you were
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a pivot in its finishing touch. You were most accurate in dealing with appointments
concerning its completion in Dick’s overfull agenda. You always managed to fit
me in. Thanks for your effort. You are a cracker!
Jeannette Lokker, Professor Lindhout’s secretary at Rotterdam, you too
deserve a word of thanks. Your handling of many appointments in the early phase
was flawless. Even after Dick had left for Utrecht, I could still count on you. Thank
you!
Rein van der Wal, hospital photographer at Zwolle. Rein, with your help the
many X-rays could be digitalised at a qualitatively very high level, of which we
gratefully made use. I hope our cooperation will continue for a long time to come.
Thanks!
Professor P. Nikkels, dear Peter. Thank you for the histological tests that were
performed with the specimens of arthrotic joints. Hopefully, we may continue to
build on the data we now have in a later stage.
Orthopaedic personnel of the Isala Clinics, location Weezenlanden, Zwolle.
Dear colleagues, dear Robert, René, George, Niek and Kees, Thank you for the
time I was given to devote myself to this study. You have also trained a doctor who
may join your ranks. Actually, the nameplate on the door: Dr. A.K. Mostert should
not be there until today!
Orthopaedic personnel and assistants of Groningen University Hospital.
Dear colleagues, I thank you too for the rare hours I was permitted to spend
“during the boss’s time” in the room where we were on duty and which still
smelled of cigars months after I had left.
J. van Deursen, MD, famous general practitioner at Zutphen, dear Jos. A
special word of thanks to you. During my final years as a radiographer, you assured
me that the study of medicine would not be aiming too high. You encouraged me to
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suit the action to the word. That is the reason why today I wanted to have you by
my side during this ceremony.
M.M.F.M. Bressers, MD, valued colleague, dear Mart. During our orthopaedic
training programme, and even before, I got to know you as a talented colleague,
whom I could always rely on. For you were always around to help. This then is the
reason that today I wanted to have you by my side during this ceremony.
Harmen Ettema, promising resident orthopaedic surgeon. Thanks for helping
me in the final phase of writing this dissertation, especially when the computer
crashed and time goes on. Even in the late evening, you were available to give
assistance.
Fred Mostert, MA, sworn translator, distant uncle, I thank you too for
correcting the English text in the final phase. You were ever accessible.
Thea Schenk, very many thanks for your assistance to make the ‘booklet’ ready
for printing in the final phase.
Members of the examined family and in particular those that have given their
assistance in contacting other familiy members. Many thanks for cooperating in
this study of which the results are presented in this thesis. Your contribution to this
study enabled a better understanding of the nature and heridity of this disease. 
L. Elsbach, MD, late fellow orthopaedic surgeon at Delft, initiator of our study.
We also wish to mention him as our study is based on a publication of his in the
Journal of Bone and Joint Surgery [B] of 1959.
Cora, my darling, what a liberty you have given me to complete this thesis in
addition to the study and the work but most of all in addition to the growing
family! The booklet is finished! Thank you for your support, love and patience.
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My parents, dear mum and dad, I am delighted that you too are present at this
event. Your interest in the study has always been a stimulus to proceed. Thanks for
who you were and are!
In imitation of the conclusion of the inaugural speech by the professor of
rheumatology in the orthopaedic surgery, Professor Pöll, lately appointed, I
conclude with his words that I endorse: 
Sit nomen Domini benedictum.
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NEDERLANDS
Dr. B.R.H. Jansen, waarde co-promotor, geachte opleider, beste doctor Jansen,
na vandaag misschien: beste Bernard (?). Door uw inspiratie en begeleiding kon
deze promotie worden gestart en afgerond. In momenten van twijfel kwam daar
weer een doortastend telefoontje, soms zelfs in de vroege nacht. Als de voortgang
enigszins stagneerde, werden de koppen weer bij elkaar gestoken. Er mocht pas een
tweede kindje komen, wanneer het tweede artikel klaar zou zijn. Een derde na het
derde enzovoorts. Indertijd waren deze belangen wederzijds in elkaar verstrengeld.
Veel dank voor het bemoedigen met de veelheid van teksten uit allerlei
achtergronden!
Prof. Dr. D. Lindhout, hooggeleerde promotor, beste Dick, met veel plezier
terugdenkend aan de vele uurtjes op je zolderkamer in Leiden, die zo vruchtbaar
bleken te zijn, maar mij maar niet snel genoeg gingen. De heerlijke (Deense)
lunches, door Lisbeth je vrouw geserveerd, zal ik niet snel vergeten. Je accuratesse
heeft zijn vruchten afgeworpen, ook al gaat dat vaak voor snijdend specialisten
trager dan gewenst. Dick, veel dank voor je prikkelende doorzettingsvermogen.
Prof. Dr. J.R. van Horn, hooggeleerde promotor, geachte opleider, beste Jim.
Vanaf het begin van het onderzoek ben jij betrokken geweest bij de opzet van de
studie. Jij hebt er steeds op aan gestuurd tijdens de opleiding tot orthopaedisch
chirurg tot een afronding te komen van de dissertatie. Toen dat net niet lukte, had
jij even het idee, dat de sigaar zou doven. Maar zie hier, even trekken en de tabak
gaat weer gloeien. Jim, na een bewogen episode op gezondheidsgebied, ben ik blij,
dat wij samen tot een goede afronding hebben kunnen komen.
Dr. P.F. Dijkstra, zeer gewaardeerde collega en nog meer als mens. Helaas
mag jij deze afronding van ons wetenschappelijk werk niet meer meemaken. De
afgelopen zomer bereikte ons dit tragische bericht. Jij bent initieel een essentiële
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schakel geweest in de radiologische bevestiging van het al dan niet zijn aangedaan
met BHMED. Ook ons laatste artikel was zonder jouw hulp nooit dat geworden,
wat het nu is. 
Dr. E. Wesby-van Swaay, beste Eveline. Toen we aanvankelijk de BHMED-
familie in kaart hadden gebracht, zochten we contact met de klinische genetica in
Rotterdam en kwamen bij jou terecht. Heel waardevol waren je opmerkingen ten
aanzien van het lichamelijk onderzoek, dat klinisch genetisch iets uitgebreider is
dan het orthopaedische. Vele familieleden hebben we wederom onderzocht en
vonden afwijkingen, waaronder ook die van de handen. Zelfs nu je in Helsinki,
Finland, zit, hebben we nog contact. Het ga je goed.
Dr. P. Heutink, beste Peter. Ondanks je vele, uitstaande onderzoekslijnen in de
klinische genetica, ben je van grote waarde geweest voor het praktisch uitwerken
van het BHMED-genoom. Wat waren wij blij met je E-mail, dat het gendefect was
gevonden. Peter, veel dank en eveneens veel succes bij je volgende stappen in de
toekomst.
Drs. N.J.G.M. Veeger, beste Nic. Wij hebben tijdens mijn academische jaar
menig uurtje ons hoofd gebroken over de MCPP-data. Speciaal dank aan jou voor
je waarde als statisticus, die mij de grondbeginselen heeft bijgebracht.
Laurieke van Kammen, lieve Laurieke, wat ben jij een centrale spil geweest in
de eerste klinische fase in Delft, waar ik de vele familieleden ’s avonds mocht
ontvangen en jij de röntgenfoto’s op voortreffelijke wijze uit het gehele land wist te
achterhalen. Heel veel dank.
Jolanda Hoekstra, “mijn” secretaresse. Jolanda, jij deed één ding, wat mijn
vrouw Cora thuis niet mag doen: mijn bureau opruimen. Wanneer ik frequent nog
maar 10 cm2 bureauruimte om te schrijven had, was jij degene, die daar een factor
10 bijtoverde. Jammer dat je ons gaat verlaten.
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Linda Offermans, secretaresse van Professor Lindhout in Utrecht, een speciaal
woord voor jou. Jij was met name in de laatste fase van de afronding een centrale
spil rondom de afwerking van de dissertatie. Zeer accuraat ging je om met
afspraken rondom de afronding in de overvolle agenda van Dick. Altijd was er een
gaatje te vinden. Dank voor je inzet. Je bent een topper!
Jeannette Lokker, secretaresse van Professor Lindhout in Rotterdam, ook jij
verdient een woord van dank. Vele afspraken in de beginfase verliepen via jou
feilloos. Ook na het vertrek van Dick naar Utrecht, kon ik nog steeds op je rekenen.
Dank!
Rein van der Wal, ziekenhuisfotograaf in Zwolle. Rein, door jouw hulp
konden de vele röntgenfoto’s op kwalitatief zeer hoog niveau worden
gedigitaliseerd, waarvan wij dankbaar gebruik hebben gemaakt. Hopelijk gaat onze
samenwerking nog lang voort. Dank!
Prof. Dr. P. Nikkels, hooggeleerde heer, beste Peter. Dank voor het
histologische onderzoek, dat werd verricht van de specimen van arthrotische
gewrichten. Hopelijk kunnen we met antistoffen in een latere fase verder bouwen
op de data, die we nu hebben.
Orthopaedische staf van de Isala Klinieken, locatie Weezenlanden, Zwolle.
Geachte collegae, beste Robert, René, George, Niek en Kees. Dank voor de tijd die
ik kreeg, om aan deze studie te werken. Jullie hebben eveneens een doctor
opgeleid, die jullie gelederen mag komen versterken. Het bordje op de deur:
Dr. A.K. Mostert mag er eigenlijk pas vanaf vandaag op hangen!
Orthopaedische staf en assistenten van het Academisch Ziekenhuis
Groningen. Geachte collegae, ook jullie dank voor de schaarse uurtjes die ik
mocht besteden in “de baas zijn tijd”, in de piketkamer, die maanden na mijn
vertrek nog naar sigaren rook.
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Drs. J. van Deursen, vermaard huisarts in Zutphen, beste Jos. Een speciaal
woord van dank aan jou. Tijdens mijn laatste jaren als radiologisch laborant
verzekerde jij mij, dat de studie geneeskunde niet te hoog gegrepen zou zijn. Je
stimuleerde om de daad bij het woord te voegen. Dat is dan ook de reden, dat ik jou
als paranimf vandaag aan mijn zij wilde hebben.
Drs. M.M.F.M. Bressers, gewaardeerd collega, beste Mart. Tijdens onze
opleiding orthopaedie, maar ook daarvoor, heb ik je leren kennen als een begaafd
collega, waar ik altijd op kon rekenen. Immer stond jij voor ons klaar. Dat is dan
ook de reden, dat ik jou als paranimf vandaag aan mijn zij wilde hebben.
Harmen Ettema, veelbelovend toekomstig orthopaedisch chirurg. Dank voor
de hulp in de laatste fase bij het schrijven van deze dissertatie, met name als de
computer het weer eens liet afweten en de tijd maar doorging. Zelfs laat in de
avond was je beschikbaar om assistentie te verlenen.
Drs. Fred Mostert, beëdigd vertaler, verre oom, ook jij bedankt voor de
correctie van het Engels in de laatste fase. Immer kon ik bij je terrecht.
Thea Schenk, zeer veel dank voor je hulp, om in de laatste fase het “boekje”
drukklaar te maken.
Leden van de onderzochte familie, en in het bijzonder diegenen die
behulpzaam zijn geweest bij het leggen van de contacten. Zeer veel dank voor uw
medewerking aan het onderzoek waarvan de resultaten in dit proefschrift zijn
beschreven.  Door uw bijdrage aan het onderzoek heeft u het mogelijk gemaakt dat
er beter inzicht is verkregen in de aard en de erfelijkheid van de aandoening.
Dr. L. Elsbach, wijlen collega orthopaedisch chirurg te Delft, initiator van ons
onderzoek. We willen hem ook noemen, omdat ons onderzoek is gebaseerd op een
publicatie van zijn hand in de Journal of Bone and Joint Surgery [B] van 1959.
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Cora, lieve schat, wat heb jij mij een vrijheid gegeven om naast de studie en het
werk, maar bovenal naast het opgroeiende gezin, deze promotie af te ronden! Het
boekje is af! Dank voor je steun, liefde en geduld.
Ouders, lieve pa en ma, wat fijn dat jullie dit moment ook nog mee mogen
maken. Jullie interesse naar het onderzoek was steeds een stimulans om door te
gaan. Dank voor wie jullie waren en zijn!
In navolging van de afsluiting van de inaugurele rede van de laatst aangestelde
hoogleraar rheumatologie in de orthopaedie, Professor Pöll, sluit ik af met zijn
woorden, die ik onderschrijf: 
Sit nomen Domini benedictum.
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The author of this thesis, Adrianus Klazinus Mostert, was born on April 30,
1962 at Winschoten, the Netherlands, as the son of a clergyman. After obtaining
his secondary school certificate at the Willem van Oranje College at Waalwijk, he
spent his compulsory military service in the Royal Dutch Navy, on board HrMs
Zuiderkruis. From 1982 to 1989, he worked as a radiographer in the X-ray
department at Leiderdorp and Harderwijk as well as in radiotherapy at Deventer
and The Hague.
From 1987 to 1989, he studied for his pre-university certificate during evening
classes. Then he started the study of medicine at the University of Amsterdam in
the same year, doing experimental surgery to detect pseudoarthroses in animal
models at the Amsterdam University teaching hospital (head Professor P.J.
Klopper). The initial degree programme was finished in three years in 1992, and
the internship was done at the State University of Leiden until 1994.
He worked as a resident orthopaedic surgeon at Delft (Reinier de Graaf
Hospital, head B.R.H. Jansen, MD, PhD) and at Zwolle (Weezenlanden Hospital,
head R.M. Castelein, MD, PhD) until 1995.
In January 1996, he started as a resident general surgeon at the Reinier de Graaf
Infirmary at Delft (head P. de Graaf, MD, PhD), and January 1998 saw him as a
resident orthopaedic surgeon in the Isala Clinics, location Weezenlanden at Zwolle
(head R.M. Castelein, MD, PhD). In 2000 he did his academic year at Groningen
University Hospital (head Professor J.R. van Horn).
In 1999 he was further trained at Stolzalpe, Austria, by professor R. Graf in
ultrasonound examination of neonatal hip development, followed by a fellowship
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in traumatology at the University Hospital of Ghent, Belgium (head Professor R.
Verdonk).
Since January 1, 2002, he has been an orthopaedic surgeon. From May 1, 2002,
he has been associated with the orthopaedic surgeons Robert Bots, Niek Tulp and
Kees Verheijen and general surgeons Adrie Blomme, André Burghard, Wilbert
Fritschy, Maarten Lopes Cardozo, Robert Pierik in the Isala Clinics, location
Weezenlanden, at  Zwolle.
He is married to Cora Mostert-Deelen, and presently they have three children:
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Figure 1. Arthrogram of the right
hip of an 8-year-old boy with
BHMED (IV-26), showing the
marked deformity of the small
bony epiphysis, especially on the
medial side, and a normal round
cartilage cover. The metaphysis
is unaffected and the acetabulum
is normally shaped.
Figure 2. The X-ray of the both hips of the same 8-year-old boy, showing the small
bony epiphyses.
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Figure 3. The X-ray of the pelvis of the same affected BHMED man at the age of 37
with a total hip arthroplasty on the left side and the marked deformity on the right
side: flattening of the epiphysis, a short and thickened collumn and evident signes of
osteoarthritis.
These are the only radiographs we could overtake of the history archives of
BHMED family members. Unfortunately, the rest of the radiographs were
annihilated due to storage problems.
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INTERNATIONAL NOMENCLATURE OF CONSTITUTIONAL 
DISORDERS OF BONE OSTEOCHONDRODYSPLASIAS
SOURCE: http://www.csmc.edu/genetics/skeletdys/
(Version December 2002)
Mode 
of
Inher-
itance
OMIM
Syn-
drome
Pre-
sent
at 
Birth
Chrom-
osomal
Locus
Gene Protein OMIM
Gene/
Protein
1. Achondroplasia group
Thanatophoric dysplasia,
Type I
AD 187600 + 4p16.3 FGFR3 FGFR3 134934
Thanatophoric dysplasia,
Type II 
AD 187610 + 4p16.3 FGFR3 FGFR3 134934
Achondroplasia AD 100800 + 4p16.3 FGFR3 FGFR3 134934
Hypochondroplasia AD 146000 – 4p16.3 FGFR3 FGFR3 134934
Other FGFR3 disorders
2. Spondylodysplastic and other perinatally lethal groups
Lethal platyspondylic
skeletal dysplasias
SP 270230 +
(San Diego type, Torrance
type, Luton type)
151210 +
Achondrogenesis type 1A AR 200600 +
3. Metatropic dysplasia group
Fibrochondrogenesis AR 228520 +
Schneckenbecken
dysplasia
AR 269250 +
Metatropic dysplasia
(various forms)
AD 156530 +
4. Short-rib dysplasia (SRP) (with or without polydactyly) group
SRP type I, Saldino-
Noonan 
AR 263530 +
SRP type II, Majewski AR 263520 +
SRP type III, Verma-
Naumoff 
AR 263510 +
SRP type IV, Beemer-
Langer 
AR 269860 +
Asphyxiating thoracic
dysplasia (Jeune)
 AR 208500 +
Chondroectodermal
Dyplasia (Ellis-van
Creveld dysplasia)
AR 225500 + 4p16
5. Atelosteogenesis-omodysplasia group
Atelosteogenesis type I
(includes ‘Boomerang
dysplasia’)
SP 108720 +
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(Continued from 
previous page)
Mode 
of
Inher-
itance
OMIM
Syn-
drome
Pre-
sent
at 
Birth
Chrom-
osomal
Locus
Gene Protein OMIM
Gene/
Protein
Omodysplasia I
(Maroteaux) 
AD 164745 +
Omodysplasia II
(Borochowitz) 
AR 258315 +
Otopalatodigital
syndrome type II 
XLR 304120 +
Atelosteogenesis Type III SP 108721 +
de la Chapelle dysplasia AR 256050 +
6. Diastrophic dysplasia group
Diastrophic dysplasia AR 222600 + 5q32-
q33 
DTDST Sul.
Transporter
Achondrogenesis 1B AR 600972 + 5q32-
q33
DTDST Sul.
Transporter
Atelosteogenesis type II AR 256050 + 5q32-
q33 
DTDST Sul.
Transporter
7. Dyssegmental dysplasia group
Dyssegmental dysplasia,
Silverman-Handmaker
type
AR  224410 +
Dyssegmental dysplasia,
Rolland-Desbuquois type
AR 224400 +
8. Type II collagenopathies
Achondrogenesis II
(Langer-Saldino) 
AD  200610 + 
12q13.1
-q13.3 
COL2A1 Type II
collagen
120140
Hypochondrogenesis AD  200610 + 
12q13.1
-q13.3 
COL2A1 Type II
collagen 
120140
Kniest dysplasia AD 156550 + 
12q13.1
-q13.3
COL2A1 Type II
collagen 
120140
Spondyloepiphyseal
dysplasia (SED)
congenital
AD 183900 + 
12q13.1
-q13.3 
COL2A1 Type II
collagen 
120140
Spondyloepimetaphyseal
dysplasia (SEMD)
Strudwick type 
AD 184250 +
12q13.1
-q13.3 
COL2A1 Type II
collagen
120140
SED with brachydactyly AD 
12q13.1
-q13.3 
COL2A1 Type II
collagen 
120140
Mild SED with premature
onset arthrosis 
AD  –
12q13.1
-q13.3
COL2A1 Type II
collagen
120140
Stickler dysplasia
(heterogeneous, some not
linked to COL2A1) 
AD 108300 +
12q13.1
-q13.3
COL2A1 Type II
collagen 
120140
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(Continued from 
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Mode 
of
Inher-
itance
OMIM
Syn-
drome
Pre-
sent
at 
Birth
Chrom-
osomal
Locus
Gene Protein OMIM
Gene/
Protein
9. Type XI collagenopathies
Stickler dysplasia
(heterogeneous)
AD 184840 + 6p21 COL11A1 Type XI
collagen 
120280
Otospondylomegaepiphys
eal dysplasia 
AR 215150 + 6p21.30 COL11A2 Type XI
collagen
120290
(OSMED) AD + 6p21.3 COL11A2 Type XI
collagen 
120290
10. Other spondyloepi-(meta)-physeal [SE(M)D] dysplasias
X-linked
spondyloepiphyseal
dysplasia tarda
XLD 313400 – Xp22.2-
p22.1
Other late-onset
spondyloepi(meta)physeal
dysplasias
AR 271650 –
(Irapa) (Namaqualand et
al.)
Progressive
pseudorheumatoid
dysplasia 
AR 208230 –
Dyggve-Melchior-
Clausen dysplasia 
AR 223800 +
Wolcott-Rallison
dysplasia 
AR 226980 –
Immuno-osseous
dysplasia-Schimke 
AR 242900 +
Opsismodysplasia AR 258480 +
Chondrodystrophic
myotonia 
AR 258480 +
(Schwartz Jampel), type
1, type 2 
AR 255800 + 1q36-34
Spondyloepiphyseal
dysplasia with joint laxity
AR 271640 +
Sponastrime dysplasia AR 271510 –
SEMD short limb –
abnormal calcification
AR 271665 +
11. Multiple epiphyseal dysplasias & pseudoachondroplasia
Pseudoachondroplasia AD 177170 –  19p12-
13.1 
COMP COMP 600310
Multiple epiphyseal
dysplasia (MED) 
AD 132400 –
(Fairbanks and Ribbing
types) 
AD 600204 –  19p12-
13.1 
COMP COMP 600310
Other MEDs ? ? 600969 –  1p32.2-
33 
COL9A2 Type IX
collagen 
120260
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Mode 
of
Inher-
itance
OMIM
Syn-
drome
Pre-
sent
at 
Birth
Chrom-
osomal
Locus
Gene Protein OMIM
Gene/
Protein
12. Chondrodysplasia punctata (stippled epiphyses group)
Rhizomelic type AR 215100 + 4p16-p14 PEX7 peroxin-7 601757
Zellweger syndrome AR 214100 + 7q11.23 PEX1
AR 214100 + 6p21.1 PEX6 peroxin-6 601498
AR 214100 + 7q11.23 PEX1 peroxin-1 602136
AR 214100 + 12 PEX5 peroxin-5
AR 214100 + 8q21.1 PEX2 peroxin-2 170993
Conradi-Hünermann type XLD 302950 + Xq28 CPXD
X-linked recessive type XLR 302940 + Xp22.3 CPXR
Brachytelephalangic type XLR 302940 + Xp22.32 ARSE aryl-
sulfatase 
E 302950
Tibial-metacarpal type AD 118651 +
Vitamin K-dependent
coagulation defect 
AR  277450 +
Other acquired and
genetic disorders
including Warfarin
embryopathy
13. Metaphyseal dysplasias
Jansen type AD 156400 + 3p22-
p21.1 
PTHR
PTHR/PTH
RP 
168468
Schmid type AD 156500 – 6q21-
q22.3 COL10
A1 
COL10
chain 
120110
McKusick type
(cartilage-hair hypoplasia) 
AR 250250 + 9p13
Metaphyseal anadysplasia XLR?  309645 –
Metaphyseal dysplasia
with pancreatic
insufficiency and cyclic
neutropenia 
(Shwachman Diamond)
AR 260400 –
Adenosine deaminase
deficiency 
AD 102700 – 20q-13.11 ADA Adenosine
deaminase
102700
Metaphyseal
chondrodysplasia-Spahr
type
AR 250400 –
Acroscyphodysplasia
(various types)
AR 250215 –
14. Spondylometaphyseal dysplasias (SMD)
Spondylometaphyseal
dysplasia Kozlowski type
AD 184252 +
Spondylometaphyseal
dysplasia (Sutcliffe type)  
AD 184255 +
SMD with severe genu
valgum (includes Schmidt
and Algerian types)  
AD 184253 +
APPENDIX 2
____________________________________________________________________
185
(Continued from 
previous page)
Mode 
of
Inher-
itance
OMIM
Syn-
drome
Pre-
sent
at 
Birth
Chrom-
osomal
Locus
Gene Protein OMIM
Gene/
Protein
SMD Sedaghatian type AR +
Mild SMD different types
that have not been well
delineated
–
15. Brachyolmia spondylodysplasias
Hobaek 
(includes Toledo type) 
AR 271530-
630
–
Maroteaux type AR –
Autosomal dominant type AD 113500 –
16. Mesomelic dysplasias
Dychondrosteosis 
(Leri-Weill) 
AD 127300 –
Langer type (homozygous
dyschondrosteosis)
AR 249700 +
Nievergelt type AD 163400 +
Kozlowski-Reardon type AR +
Reinhardt-Pfeiffer type AD 191400 +
Werner type AD +
Robinow type, dominant AD 180700 –
Robinow type, recessive AR 268310 –
Mesomelic dysplasia with
synostoses 
AD 600383 +
17. Acromelic and acromesomelic dysplasias
Acromicric dysplasia AD 102370 +
Geleophysic dysplasia AR 231050 +
Weill-Marchesani
dysplasia 
AR 277600 +
Cranioectodermal
dysplasia 
AR 218330 +
Trichorhinophalangeal
dysplasia, type I 
AD 190350 +  8q24.12 TRPS1
Trichorhinophalangeal
dysplasia, type II 
(Langer-Giedeon)
AD 150230 + 
8q24.11
-q24.13 
TRPS1+
EXT1
Trichorhinophalangeal
dysplasia, type III 
AD 190351 +  
Grebe dysplasia AR 200700 +  20q11.2 CDMP1 cartilage
derived
morphogenic 
protein 1
601146
Hunter-Thompson
dysplasia 
AR 201250 +  20q11.2 CDMP1 cartilage
derived
morphogenic 
protein 1
601146
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Mode 
of
Inher-
itance
OMIM
Syn-
drome
Pre-
sent
at 
Birth
Chrom-
osomal
Locus
Gene Protein OMIM
Gene/
Protein
Brachydactyly type 
A1-A4 
AD 112500-
800
+
Brachydactyly type B AD 113000 +
Brachydactyly type C AD 133100 + 21q11 CDMP1 cartilage
derived
morphogenic
protein 1
601196
AD 12q24
Brachydactyly type D AD 113200 +
Brachydactyly type E AD 113000 –
Pseudohypopara-
thyroidism
(Albright Hereditary
Osteodystrophy), 
various types, see OMIM
 20q13  GNAS1 quanine
nucleotide
binding
protein of
edenylate
cyclase 
-subunit
139320
Acrodysostosis SP
(AD) 
101800 –
Saldino-Mainzer
dysplasia 
AR 266920 –
Brachydactyly-
hypertension dysplasia
(Bilginturan)
AD 112410 +  12p
Craniofacial
conodysplasia 
AD +
Angel-shaped phalango-
epiphyseal dysplasia
(ASPED)
AD 105835 +
Acromesomelic dysplasia AR 201250 +
Other acromesomelic
dysplasias
18. Dysplasias with prominent membranous bone involvement
Cleidocranial dysplasia AD 119600 +  6p21 CBFA1 core binding
factor 
-subunit 
600211
Osteodysplasty, Melnick-
Needles 
XLD 309350 –
Precocious osteodysplasty
(terHaar dysplasia)
AR +
Yunis-Varon dysplasia AR 216340 +
19. Bent-bone dysplasia group
Campomelic dysplasia AD 114290 +  7q24.3-
q25.1 
SOX9 SRY-box 9 211970
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Mode 
of
Inher-
itance
OMIM
Syn-
drome
Pre-
sent
at 
Birth
Chrom-
osomal
Locus
Gene Protein OMIM
Gene/
Protein
Kyphomelic dysplasia ?AR 211350 +
Stüve-Wiedemann
dysplasia 
AR 601559 +
20. Multiple dislocations with dysplasias
Larsen syndrome AD 150250 + 3p21.1-
p14.1 
LARI
Larsen-like syndromes
(including La Reunion
Island)
AR 245600 +
Desbuquois dysplasia AR 251450 +
Pseudodiastrophic
dysplasia 
AR 264180 +
21. Dysostosis multiplex group
Mucopolysaccharidosis
IH 
AR 252800 – 4p16.3 IDA -1-
Iduronid-
ase
Mucopolysaccharidosis 
IS 
AR 252800 – 4p16.3 IDA -1-
Iduronid-
ase
Mucopolysaccharidosis
II 
XLR 309900 – Xq27.3-
q28 
IDS Iduronate-
2-sulfatase
Mucopolysaccharidosis
IIIA 
AR 252900 – 17q25.3 HSS Heparan
sulfate
sulfatase
Mucopolysaccharidosis
IIIB 
AR 252920 17q21 N-Ac--
D-glucos-
aminidase
Mucopolysaccharidosis
IIIC 
AR 252930 – Ac-CoA:
-glucos-
aminidase-
N-acetyl-
transferase
Mucopolysaccharidosis
IIID 
AR 252940 – 12q14 GNS N-Ac-
glucos-
amine-6-
sulfatase
Mucopolysaccharidosis
IVA 
AR 230500 – 16q24.3 GALNS Galactose-
6-sulfatase
Mucopolysaccharidosis
IVB 
AR 230500 – 3p21.33 GLBI -
Galactosid
-ase
Mucopolysaccharidosis
VI 
AR 253200 – 5q13.3 ARSB 
Arylsulfat
ase B
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of
Inher-
itance
OMIM
Syn-
drome
Pre-
sent
at 
Birth
Chrom-
osomal
Locus
Gene Protein OMIM
Gene/
Protein
Mucopolysaccharidosis
VII 
AR 253200 – 7q21.11 GUSB -
Glucuronid-
ase
Fucosidosis AR 230000 – 1p34 FUCA -
Fucosidase
- Mannosidosis AR 248500 –
19p13.2
-q12 
MAN -Mannosid-
ase
- Mannosidosis AR 248510 – 4 MANB -Mannosid-
ase
Aspartylglucosaminuria AR 208400 – 4q23-
q27 
AgA Aspartyl-
glucos-
aminidase
GM1 Gangliosidosis,
several forms 
AR 230500 + 3p21-
p14.2
GLB1 -Galactos-
idase
Sialidosis, 
several forms 
AR 256550 +/– 6p21.3 NEU -Neuramin-
idase
Sialic acid storage disease AR 269920 +/–  6q14-
q15 
SIASD
Galactosialidosis, 
several forms 
AR 256540 20q13.1 PPGB -Galact-
osidase
protective
protein
Multiple sulfatase
deficiency 
AR 272200 +/– Multiple
sulfatases
Mucolipidosis II AR 252500 + 4q21-23 GNPTA N-Ac-
Glucosamine
phosphotran
sferase
Mucolipidosis III AR 252600 – 4q21-23 GNPTA N-Ac-
Glucosamine
phosphotans
ferase
22. Osteodysplastic slender bone group
Type I osteodysplastic
dysplasia 
AR 210710 +
Type II osteodysplastic
dysplasia 
AR 210720 +
Microcephalic
osteodysplastic dys. 
AR
23. Dysplasias with decreased bone density
Osteogenesis imperfecta I
(without opalescent teeth)
AD 166200 +/– 17q21 COL1A1 (1) I pro-
collagen 
120150
Osteogenesis imperfecta I
(with opalescent teeth)
AD 166240 +/– 17q21 COL1A1 (1)I pro-
collagen 
120150
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of
Inher-
itance
OMIM
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drome
Pre-
sent
at 
Birth
Chrom-
osomal
Locus
Gene Protein OMIM
Gene/
Protein
AD  166240 +/- 7q22.1 COL1A2 (2)I pro-
collagen 
120160
Osteogenesis imperfecta
II 
AD 166210 + 17q21
COL1A
1 
(1)I
procollag
en
120150
AD 166210 + 7q22.1 COL1A2 (2)I pro-
collagen 
120160
AR 259400 + 17q21 COL1A1 (1)I pro-
collagen 
120150
Osteogenesis imperfecta
III 
AD 259420 + 17q21 COL1A1 (1)I pro-
collagen 
120150
AD 259420 + 7q22.1 COL1A2 (2)I pro-
collagen 
120160
AR 259420 + 7q22.1 CO L1A2 (2)I pro-
collagen 
120160
AR 259420 +
Osteogenesis imperfecta
IV
(without opalescent teeth)
AD 166220 + 7q22.1 COL1A2 (2)I pro-
collagen
120160
AD 166220 + 17q21 COL1A1 (1)I pro-
collagen 
120150
Osteogenesis imperfecta
IV
(with opalescent teeth)
AD 166220 + 7q22.1 COL1A2 (2)I pro-
collagen 
120160
AD 166220 + 17q21 COL1A1 (1)I pro-
collagen 
120150
Cole-Carpenter dysplasia SP 112240 +
Bruck dysplasia AR 259450 +
Singleton-Merton
dysplasia 
AR
Osteopenia with
radiolucent lesions of the
mandible
AD 166260
Osteoporosis-
pseudoglioma dysplasia 
AR 259770 – 11q12-
q13
Geroderma
osteodysplasticum 
AR 231070 –
Hyper IGE syndrome 
with osteopenia 
AR 147060 –
Idiopathic juvenile
osteroporosis 
SP 259750 –
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Protein
24. Dysplasias with defective mineralization
Hypophosphatasia-
perinatal lethal and
infantile forms
AR 241500 + 1p36.1-
p34 
ALPL alkaline
phosphat-ase 
171760
Hypophosphatasia adult
form 
AD 146300 – 1p36.1-
p34
Hypophosphatemic
rickets 
XLD 307800 – Xp22.2-
p22.1 
PHEX X-linked
hypophos-
phatemia
protein
171760
Neonatal
hyperparathyroidism 
AR 239200 + 3q21-
q24,
19p13.3 
CASR calcium
sensor
 601199
Transient neonatal
hyperparathyrodism with
hypocalciuric
hypercalcemia
AD 145980 + 3q21-
q24 
CASR calcium
sensor 
601199
AD + 19p13.3
25. Increased bone density without modification of bone shape
Osteopetrosis
Precocious   typ4e AR 259700 + 11q12-
13
     Delayed type AD 166600 – 1p21
Intermediate type AR 259710 +
With renal tubular
acidosis 
AR 259730 + 8q22 CA2 carbonic
anhydrase II
Axial osteosclerosis
Osteomeso-pyknosis AD 166450 –
With bamboo hair AR 266500 –
Pyknodysos
tosis 
AR 265800 +  1q21  CTSK cathepsin K 601105
Osteo-sclerosis
Stanescu 
type 
AD 122900 +
Osteopathia striata
Isolated SP –
With cranial sclerosis AD 166500 –
Sponastrime dysplasia AR 271510 +
Melorheostosis SP 155950 –
Osteopoikilosis AD 166700 –
Mixed sclerosing bone
dysplasia 
SP –
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26. Increased bone density with diaphyseal involvement
Diaphyseal dysplasia
Camurati Engelmann
AD 131300 –
Craniodiaphyseal
dysplasia 
?AR 218300,
122860
+
Lenz Majewski dysplasia SP 151050 +
Endosteal hyperostosis 
van Buchem type AR 239100 –
Worth type AD 144750 –
Sclerosteosis AR 269500 –
With cerebellar
hypoplasia 
AR 213002 +
Kenny Caffey dysplasia AD,
AR 
127000,
244460
–
Osteoectasia with
hyperphos-phatasia 
(Juvenile Pagets) 
AR 39000 –
Diaphyseal dysplasia with
anemia 
AR 231095 –
Diaphyseal medullary
stenosis with bone
malignancy (Hardcastle)
AD 112250 –
27. Increased bone density with metaphyseal involvement
Pyle dysplasia AR 265900 –
Craniometaphyseal
dysplasia
 
Severe type AR 218400 +
Mild type AD 123000 – 5p15.2-
p14.2
Other types
Frontometaphyseal
dysplasia 
XLR 305620 –
Dysosteosclerosis AR 
XLR
224300 –
Oculodentoosseous
dysplasia 
AD 257850 +
AR 164200 +
Trichodentoosseous
dysplasia 
AD 190320 –  17q21
28. Neonatal severe osteosclerotic dysplasias
Blomstrand dysplasia AR 215045 +
Raine dysplasia ? 259775 +
Prenatal onset Caffey
disease ?
AR 114000 +
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29. Lethal chondrodysplasias with fragmented bones
Greenberg dysplasia AR 215140 +
Dappled diaphyseal
dysplasia 
AR +
Astley-Kendall dysplasia AR  +
30. Disorganized development of cartilaginous and fibrous components of the skeleton
Dysplasia epiphysealis
hemimelica 
SP 127800 –
Multiple cartilaginous
exostoses 
AD 133700 – 8q23-
q24.1 
EXT1 exostosin-
1
AD 133701 – 11p12-
p11 
EXT2 exostosin-
2
AD 600209 – 19p
EXT3
Enchondromatosis, Ollier SP 166000 –
Enchondromatosis with
hemangiomata (Maffucci)
SP 166000 –
Spondyloenchondro-
matosis 
AR 271550 –
Spondyloenchondro-
matosis with basal ganglia
calcification 
AR –
Dysspondyloenchondro-
matosis 
–
Metachondroma-tosis AD 156250
Osteoglophonic dysplasia AD 166250 +
Genochondromatosis AD 166000 –
Carpotarsal
osteochondromatosis 
AD 127820 –
Fibrous dysplasia
(McCune-Albright and
others) 
SP
mosaic
174800 –  20q13 GNAS1 guanine
nucleotide
protein,
subunit
139320
Jaffe Campanucci SP
Fibrodysplasia ossificans
progressiva
AD 135100 +  14q22-
q23 
BMP4 bone
morphoge
nic protein 
4
112262
Cherubism AD 118400 –
Cherubism with gingival
fibromatosis 
AR 135300 –
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31. Osteolyses
Multicentric predominantly carpal & tarsal in the hand
Multicentric carpal-tarsal
osteolysis with and
without nephropathy
AD 166300 –
Shinohara carpal-tarsal
osteolysis 
–
Multicentric predominantly carpal, tarsal and interphalangeal
Francois syndrome AR 221800 –
Winchester syndrome AR 277950 –
Torg syndrome AR 259600 –
Whyte Hemingway
carpal-tarsal phalangeal
osteolyses
AD –
Predominantly distal phalanges 
Hadju-Cheney syndrome AD 102500  –
Giacci familial
neurogenic acroosteolysis 
AR 201300  –
Mandibulo acral
syndrome 
AR 248370 –
Predominantly involving diaphyses and metaphyses
Familial expansile
osteolysis 
AD 174810 –
18q21.1
-q22
Juvenile hyaline
fibromatosis 
AR 228600 +
32. Patella dysplasias
Nail patella dysplasia AD 161200 – 9q34.1 NPS1
Scypho-patellar dysplasia AD +
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SPONSORS
Bauerfeind Benelux B.V. Haarlem
B. Braun Medical B.V. Oss
Cremersfonds Isala Klinieken Zwolle
DePuy Acromed Amersfoort
Hodes® Group Arnhem
Mathys Medical Nederland B.V. Zeist
Nederlandse Orthopaedische Vereniging Nijmegen
New Deal Grimbergen
Ortomed B.V. Zwijndrecht
Procter & Gamble Pharmaceuticals Rotterdam
Rx Medical Schiedam
Sanofi-Synthelabo B.V. Maassluis
Stryker Howmedica Osteonics Eindhoven
Ten Doesschatefonds / ZWIK Zwolle
